<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29375819</article-id>
<article-id pub-id-type="pmc">5760969</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.12155.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; referees: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Selten</surname>
<given-names>Martijn</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data Curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Bokhoven</surname>
<given-names>Hans</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2153-9254</contrib-id>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nadif Kasri</surname>
<given-names>Nael</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data Curation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<aff id="a1">
<label>1</label>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, New Hunt's House, Guy's Campus, King’s College London, London, SE1 1UL, UK</aff>
<aff id="a2">
<label>2</label>MRC Centre for Neurodevelopmental Disorders, New Hunt's House, Guy's Campus, King’s College London, London, SE1 1UL, UK</aff>
<aff id="a3">
<label>3</label>Department of Human Genetics &amp; Department of Cognitive Neuroscience, Radboudumc, Geert Grooteplein 10, Box 9101, 6500 HB Nijmegen, Netherlands</aff>
<aff id="a4">
<label>4</label>Donders Institute for Brain, Cognition, and Behaviour, Centre for Neuroscience, 6525 AJ Nijmegen, Netherlands</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:Hans.vanbokhoven@radboudumc.nl">Hans.vanbokhoven@radboudumc.nl</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>8</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>7</volume>
<elocation-id>23</elocation-id>
<history>
<date date-type="accepted">
<day>21</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2018 Selten M et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-7-13157.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Neuronal networks consist of different types of neurons that all play their own role in order to maintain proper network function. The two main types of neurons segregate in excitatory and inhibitory neurons, which together regulate the flow of information through the network. It has been proposed that changes in the relative strength in these two opposing forces underlie the symptoms observed in psychiatric disorders, including autism and schizophrenia. Here, we review the role of alterations to the function of the inhibitory system as a cause of psychiatric disorders. First, we explore both patient and post-mortem evidence of inhibitory deficiency. We then discuss the function of different interneuron subtypes in the network and focus on the central role of a specific class of inhibitory neurons, parvalbumin-positive interneurons. Finally, we discuss genes known to be affected in different disorders and the effects that mutations in these genes have on the inhibitory system in cortex and hippocampus. We conclude that alterations to the inhibitory system are consistently identified in animal models of psychiatric disorders and, more specifically, that mutations affecting the function of parvalbumin-positive interneurons seem to play a central role in the symptoms observed in these disorders.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>psychiatric disorders</kwd>
<kwd>PV basket cells</kwd>
<kwd>PV interneurons</kwd>
<kwd>chandelier cells</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/browse/f1000-faculty-reviews">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Rhiannon Meredith</named-content>, Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, Netherlands
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Hisashi Umemori</named-content>, Department of Neurology, FM Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Psychiatric disorders, including autism, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder (ADHD) and depression, affect millions of people and are a major socio-economic burden
<sup><xref ref-type="bibr" rid="ref-1">1</xref>–
<xref ref-type="bibr" rid="ref-3">3</xref></sup>. The identification of underlying genetic defects and risk factors is becoming increasingly efficient because of genome-wide interrogation methodologies, yet owing to the complex multifactorial origin of most cases, a conclusive molecular diagnosis is made for only a minority of patients. Therefore, the underlying causes for these conditions are poorly understood, and often treatment is still based on symptomology
<sup><xref ref-type="bibr" rid="ref-4">4</xref>–
<xref ref-type="bibr" rid="ref-6">6</xref></sup>. In 2003, Rubenstein and Merzenich proposed autism spectrum disorders (ASDs) to be caused by an increase in the ratio between excitation and inhibition, called the E/I balance
<sup><xref ref-type="bibr" rid="ref-7">7</xref></sup>. Since then, this hypothesis has been substantiated by a vast number of studies and also has been implicated in other psychiatric disorders such as schizophrenia
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>, consistent with their partially overlapping phenotypes
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>. Recently, the focus has shifted to changes to the inhibitory side of the E/I balance
<sup><xref ref-type="bibr" rid="ref-10">10</xref>,
<xref ref-type="bibr" rid="ref-11">11</xref></sup>, in particular to one class of inhibitory neurons, parvalbumin (PV)-positive interneurons
<sup><xref ref-type="bibr" rid="ref-12">12</xref></sup>. In this review, we focus on the role of the inhibitory system in psychiatric disorders and explore the changes to the inhibitory systems in different disorders. We then discuss the role and function of PV interneurons and highlight the changes to this specific class of interneurons in the various psychiatric disorders.</p>
</sec>
<sec>
<title>Evidence for inhibitory dysfunction in psychiatric disorders</title>
<p>Since Rubenstein and Merzenich postulated their hypothesis of a reduced E/I balance in ASDs, there has been an increasing amount of evidence for disrupted inhibitory control in psychiatric disorders. This evidence comes from post-mortem studies and studies of patient phenotypes.</p>
<p>Firstly, post-mortem studies on patient brains have revealed consistent changes to the inhibitory system in various disorders. Studies of autistic brains revealed reduced expression of the gamma-aminobutyric acid (GABA) synthesizing enzymes GAD65 and GAD67, as well as various GABA receptor subunits, in parietal cortex and cerebellum
<sup><xref ref-type="bibr" rid="ref-13">13</xref>,
<xref ref-type="bibr" rid="ref-14">14</xref></sup>. In schizophrenia, reductions of interneuron markers have been found in the prefrontal cortex
<sup><xref ref-type="bibr" rid="ref-15">15</xref>–
<xref ref-type="bibr" rid="ref-18">18</xref></sup>, a region strongly implicated in this condition
<sup><xref ref-type="bibr" rid="ref-19">19</xref></sup>. Interestingly, in recent years, this reduction has been shown to be caused by a reduction of the expression of the interneuron markers rather than a reduction of the number of interneurons
<sup><xref ref-type="bibr" rid="ref-20">20</xref>–
<xref ref-type="bibr" rid="ref-22">22</xref></sup>, which indicates reduced activity of these neurons
<sup><xref ref-type="bibr" rid="ref-23">23</xref>–
<xref ref-type="bibr" rid="ref-25">25</xref></sup>. In addition, both increased and decreased numbers of specific interneuronal subtypes are reported in bipolar disorder
<sup><xref ref-type="bibr" rid="ref-17">17</xref>,
<xref ref-type="bibr" rid="ref-26">26</xref></sup>, while a reduced inhibitory function is reported in depression
<sup><xref ref-type="bibr" rid="ref-27">27</xref>,
<xref ref-type="bibr" rid="ref-28">28</xref></sup> and bipolar disorder
<sup><xref ref-type="bibr" rid="ref-29">29</xref></sup>.</p>
<p>Secondly, patients with psychiatric disorders display phenotypes that are strongly correlated to impaired inhibition. Epilepsy is a common comorbidity with psychiatric disorders and has consistently been linked to impaired inhibitory function
<sup><xref ref-type="bibr" rid="ref-30">30</xref>–
<xref ref-type="bibr" rid="ref-33">33</xref></sup>. In patients with autism, it is estimated that the prevalence of epilepsy comorbidity is around 25%
<sup><xref ref-type="bibr" rid="ref-34">34</xref>,
<xref ref-type="bibr" rid="ref-35">35</xref></sup>. However, this is dependent on the type of autism, and the prevalence can be as high as 80% in Rett syndrome
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>, a monogenic form of autism caused by mutation in the
<italic>MeCP2</italic> gene
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>. It is currently unclear whether schizophrenia is a risk factor for epilepsy. A limited number of studies have been dedicated to this question, and contradicting results have been reported
<sup><xref ref-type="bibr" rid="ref-38">38</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>. However, patients with epilepsy show an increased risk of schizophrenia or schizophrenia-like psychosis
<sup><xref ref-type="bibr" rid="ref-40">40</xref></sup>. Likewise, patients with epilepsy show an increased risk for ADHD
<sup><xref ref-type="bibr" rid="ref-41">41</xref>,
<xref ref-type="bibr" rid="ref-42">42</xref></sup>.</p>
<p>Another recurrent phenotypic change is the altered power of gamma oscillations, as measured with electroencephalography or magnetoencephalography in humans, indicating changes in neuronal synchrony
<sup><xref ref-type="bibr" rid="ref-43">43</xref></sup>. Gamma oscillations are important for integration of information in neuronal circuits and have been linked to various functions, including attention
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup> and memory
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>. It was shown that PV-positive interneurons
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>, specifically PV-positive basket cells (see below), play an important role in these osciliations
<sup><xref ref-type="bibr" rid="ref-43">43</xref>,
<xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-48">48</xref></sup>. Changes in gamma oscillations are consistently found in patients with schizophrenia
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>, affecting different regions, including the prefrontal cortex
<sup><xref ref-type="bibr" rid="ref-50">50</xref>,
<xref ref-type="bibr" rid="ref-51">51</xref></sup>. Interestingly, while a decrease in gamma power is linked to negative symptoms of this disorder, such as psychomotor poverty
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>, increased gamma power has been observed during positive symptoms, such as hallucinations
<sup><xref ref-type="bibr" rid="ref-53">53</xref></sup>. In addition, computational studies suggest a central role for inhibitory synaptic scaling in maintaining a stable neuronal network
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup> and found changes in inhibitory transmission to be sufficient to explain the changes in gamma oscillations in schizophrenia
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>. Together, altered inhibitory control is believed to lead to a change in the power of gamma oscillations, which play a central role in schizophrenia
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>.</p>
<p>Though studied mainly in schizophrenia, changes in gamma oscillations have been observed in other psychiatric disorders, including autism, ADHD and bipolar disorder
<sup><xref ref-type="bibr" rid="ref-57">57</xref>–
<xref ref-type="bibr" rid="ref-63">63</xref></sup>. For example, children with autism show a reduced gamma frequency modulation to a visual task
<sup><xref ref-type="bibr" rid="ref-64">64</xref></sup>, whereas in ADHD, increased power and synchrony were observed
<sup><xref ref-type="bibr" rid="ref-59">59</xref>–
<xref ref-type="bibr" rid="ref-62">62</xref></sup>. Together, post-mortem and patient studies point to an important role for altered inhibitory function in various psychiatric disorders and indicate a vital role for inhibition in the maintenance of the E/I balance in the healthy brain.</p>
</sec>
<sec>
<title>The central role of parvalbumin-positive interneurons in E/I balance</title>
<p>Cortical and hippocampal synaptic inhibition is mediated by inhibitory interneurons, most of which use GABA as their neurotransmitter. While interneurons make up around 20% of the total neuronal population, they are highly diverse
<sup><xref ref-type="bibr" rid="ref-65">65</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref></sup>. For example, different classes of interneurons are specialized to target the dendrites, soma or axon initial segment (AIS) of pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-65">65</xref></sup>. This large variety of cell types is believed to illustrate the distinct functions that these cells have in regulation of the network
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>. Cortical interneurons can be segregated in three non-overlapping groups by means of specific markers: PV, somatostatin (SOM) and the serotonin receptor 3a (5HT3aR), accounting for 40%, 30% and 30% of the total interneuron population, respectively
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>. 5HT3aR-positive cells mainly originate from the caudal ganglionic eminence and are further divided as vasoactive intestinal peptide (VIP)-positive and VIP-negative interneurons
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>. VIP-positive interneurons mainly inhibit other interneurons and play an important role in disinhibition of the local circuit
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>, where they receive excitatory input from other cortical areas
<sup><xref ref-type="bibr" rid="ref-70">70</xref>,
<xref ref-type="bibr" rid="ref-71">71</xref></sup>. VIP cells mainly inhibit SOM cells
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup> but also target PV interneurons
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup> and are involved in the regulation of the behavioural state of the network
<sup><xref ref-type="bibr" rid="ref-71">71</xref>,
<xref ref-type="bibr" rid="ref-73">73</xref></sup>. Recent studies have suggested a direct inhibition by VIP interneurons of pyramidal cells in cortex
<sup><xref ref-type="bibr" rid="ref-74">74</xref>,
<xref ref-type="bibr" rid="ref-75">75</xref></sup>. Despite the prominent, mainly disinhibitory, function of VIP cells in the network, only a limited number of studies have implicated VIP cells to be involved in psychiatric disorders
<sup><xref ref-type="bibr" rid="ref-26">26</xref>,
<xref ref-type="bibr" rid="ref-76">76</xref></sup>.</p>
<p>SOM interneurons are a diverse class of interneurons originating from the medial ganglionic eminence (MGE)
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>. These interneurons target non-SOM interneurons
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup> as well as the dendritic domain of pyramidal neurons, including dendritic spines
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>. SOM interneurons regulate the integration of local excitatory input
<sup><xref ref-type="bibr" rid="ref-78">78</xref>,
<xref ref-type="bibr" rid="ref-79">79</xref></sup> and have been shown to regulate synaptic plasticity via the control of dendritic calcium spikes in pyramidal cells, affecting learning tasks
<sup><xref ref-type="bibr" rid="ref-80">80</xref></sup>. Increasing evidence implicates SOM interneurons in psychiatric disorders. Disinhibition of SOM interneurons leads to an anti-depressive–like phenotype in mice
<sup><xref ref-type="bibr" rid="ref-81">81</xref></sup>, and reduced levels of SOM in cerebral spinal fluid have been linked to major depression and mood disorders
<sup><xref ref-type="bibr" rid="ref-82">82</xref></sup>. In addition, a recent article shows a role for SOM interneurons in gamma oscillations in the visual cortex
<sup><xref ref-type="bibr" rid="ref-83">83</xref></sup>, hinting towards a possible role for SOM interneurons in the changes in gamma oscillations observed in psychiatric disorders.</p>
<p>PV interneurons are MGE-derived and are electrophysiologically identified by their fast-spiking phenotype. Although PV interneurons make up only a small part of the entire neuronal population
<sup><xref ref-type="bibr" rid="ref-84">84</xref>,
<xref ref-type="bibr" rid="ref-85">85</xref></sup>, these interneurons are strongly implicated in psychiatric disorders and have been shown to play an important role in the regulations of the E/I balance
<sup><xref ref-type="bibr" rid="ref-8">8</xref>,
<xref ref-type="bibr" rid="ref-10">10</xref>,
<xref ref-type="bibr" rid="ref-86">86</xref></sup>. PV interneurons are involved in gamma oscillations (see above), and various mutations in disease-linked genes affect PV interneuron function (discussed below) (
<xref ref-type="table" rid="T1">Table 1</xref>). Different subtypes of PV interneurons are distinguished: basket cells, chandelier cells, bistratisfied cells, and, in hippocampus, oriens-alveus-lacunosum-moleculare cells
<sup><xref ref-type="bibr" rid="ref-87">87</xref>,
<xref ref-type="bibr" rid="ref-88">88</xref></sup> form the largest of these groups, the first two of which are most widely studied. Here, we will discuss both types and focus on their respective roles in the network.</p>
<table-wrap id="T1" orientation="portrait" position="anchor">
<label>Table 1. </label>
<caption>
<title>Genes linked to psychiatric disorders affect distinct subcellular aspects.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Aspect</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Syndrome/Disorder</th>
<th align="left" colspan="1" rowspan="1" valign="top">Model</th>
<th align="left" colspan="1" rowspan="1" valign="top">Investigated
<break></break>region</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="6" valign="top">Input</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Erbb4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV interneuron KO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced excitatory input to
<break></break>PV basket cells and chandelier cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-120">120</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nrg1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">NRG1 treatment of
<break></break>dissociated cortical
<break></break>cultures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical
<break></break>(cultures)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased excitatory synapse
<break></break>number onto interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-121">121</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Fmr1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fragile X syndrome;
<break></break>ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Fmr1</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced local excitatory input
<break></break>onto FS interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-122">122</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DISC1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ, ASD, depressive
<break></break>disorder, BD</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV-specific shRNA
<break></break>KD
<italic>in vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased excitatory input onto PV
<break></break>interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-123">123</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV interneuron KO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus
<break></break>Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased NMDAR responses
<break></break>Increased glutamate release onto
<break></break>PV interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-124">124</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Mecp2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett syndrome; ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV interneuron KO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced local excitatory input
<break></break>onto PV interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-125">125</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">Intrinsic</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Mecp2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett syndrome; ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV interneuron KO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased intrinsic excitability of
<break></break>PV interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-125">125</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Dysbindin</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Dysbindin</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced excitability of FS
<break></break>interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-126">126</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Scn1a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dravet syndrome;
<break></break>ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Scn1a</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired action potential kinetics
<break></break>in interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-127">127</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Shank3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD, SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Shank3B</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex, Striatum</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced activity of PV
<break></break>interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-22">22</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="12" valign="top">Output</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Erbb4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV interneuron KO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced cartridges from
<break></break>chandelier cells onto pyramidal
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-120">120</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nrg1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">Overexpression in
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased basket cell and
<break></break>chandelier cell boutons onto
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-128">128</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Tsc1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tuberous sclerosis;
<break></break>ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sparse
<italic>Tsc1</italic> deletion
<break></break>in CA1 pyramidal
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory synaptic
<break></break>strength onto pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-129">129</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Ube3a</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angelman syndrome;
<break></break>ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal loss of
<break></break>
<italic>Ube3a</italic> mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory drive from FS
<break></break>and non-FS interneurons onto
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-130">130</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Shank3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD, SZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Shank3-exon9</italic> KO
<break></break>mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory input onto
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-131">131</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Shank3-exon9</italic> KO
<break></break>mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased inhibitory input onto pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-131">131</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Git1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ADHD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Git1</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory inputs onto
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-132">132</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Cdh13</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ADHD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Cdh13</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased number of inhibitory
<break></break>synapses onto pyramidal neurons </td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-133">133</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn 2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn2</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory drive onto
<break></break>pyramidal neurons from FS
<break></break>interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-134">134</xref>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn2</italic> KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced number of perisomatic
<break></break>synapses onto pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-135">135</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn 3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Nlgn3</italic> R451C mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory drive from
<break></break>PV basket cells onto pyramidal
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-136">136</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Cntnap2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>shRNA</italic> KD in
<break></break>dissociated cortical
<break></break>cultures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical
<break></break>(cultures)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced inhibitory drive onto
<break></break>pyramidal neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="ref-137">137</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; BD, bipolar disorder; FS, fast-spiking; KD, knockdown; KO, knockout; PV, parvalbumin-positive; shRNA, short hairpin RNA; SZ, schizophrenia.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec>
<title>PV basket cells</title>
<p>Basket cells are the largest group of PV interneurons and specifically target the soma and proximal dendrite of pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-87">87</xref></sup>. The perisomatic location of these axon terminals allows PV basket cells to have a strong control over the excitability of pyramidal neurons. Among other cortical inputs, PV basket cells receive the same excitatory input as their pyramidal cell targets, wiring the basket cell into a feed-forward circuit: excitatory input will excite both the PV basket cell and the pyramidal neuron, followed by the PV basket cell inhibiting the pyramidal neuron. The delay between the excitatory and inhibitory input onto the pyramidal cell creates a coincidence detection window, in which excitatory input can summate to elicit an action potential in the pyramidal cell
<sup><xref ref-type="bibr" rid="ref-89">89</xref></sup>. If inhibitory input arrives at the pyramidal cell before an action potential is evoked, the somatic targeted GABA action will prevent action potential initiation. So PV basket cells allow action potential initiation in pyramidal neurons only if the excitatory information is time-locked and of sufficient strength.</p>
<p>In order to mediate fast inhibition, PV basket cells are optimized for fast signalling
<sup><xref ref-type="bibr" rid="ref-85">85</xref></sup>. Action potentials are initiated at the AIS and propagate at high velocities through the axon
<sup><xref ref-type="bibr" rid="ref-90">90</xref></sup> which is enriched for the fast sodium channel Na
<sub>V</sub>1.1
<sup><xref ref-type="bibr" rid="ref-91">91</xref></sup>. Synaptically, calcium inflow is mediated by fast P/Q-type calcium channels
<sup><xref ref-type="bibr" rid="ref-92">92</xref></sup>, which are located directly adjacent to the release site
<sup><xref ref-type="bibr" rid="ref-93">93</xref></sup>. The post-synaptic site, on the pyramidal neuron, contains the fast GABAAα1 receptor subunit
<sup><xref ref-type="bibr" rid="ref-94">94</xref></sup>. These fast properties ensure an optimal speed of PV basket cell signalling and tightly regulate coincidence detection windows of pyramidal neurons.</p>
</sec>
<sec>
<title>Chandelier cells</title>
<p>Chandelier cells, or axo-axonic cells, are a group of interneurons that target the AIS of pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-95">95</xref>,
<xref ref-type="bibr" rid="ref-96">96</xref></sup>. These cells form vertically oriented clusters of axon terminals, called cartridges, giving them a chandelier-like appearance. A single pyramidal cell receives contacts from multiple chandelier cells
<sup><xref ref-type="bibr" rid="ref-97">97</xref></sup>, forming an average of 3 to 5 boutons each
<sup><xref ref-type="bibr" rid="ref-98">98</xref></sup> depending on the brain region
<sup><xref ref-type="bibr" rid="ref-99">99</xref></sup> and age
<sup><xref ref-type="bibr" rid="ref-100">100</xref></sup>. The synapses are enriched for the GABAAα2 receptor subunit
<sup><xref ref-type="bibr" rid="ref-101">101</xref>,
<xref ref-type="bibr" rid="ref-102">102</xref></sup> and pre-synaptically express the high-affinity GABA transporter 1 (GAT1)
<sup><xref ref-type="bibr" rid="ref-103">103</xref></sup>. The function of chandelier cells in the network remains largely unknown. However, chandelier cell activity has been shown to increase with increasing network activity
<sup><xref ref-type="bibr" rid="ref-104">104</xref></sup>. In addition, the axon terminals of chandelier cells are specifically absent from the epileptic focus
<sup><xref ref-type="bibr" rid="ref-105">105</xref>,
<xref ref-type="bibr" rid="ref-106">106</xref></sup>, and pharmacological induction of seizures leads to a loss of chandelier cells in rats
<sup><xref ref-type="bibr" rid="ref-107">107</xref></sup>, suggesting a role in preventing excessive excitatory activity in the network for these interneurons
<sup><xref ref-type="bibr" rid="ref-104">104</xref></sup>.</p>
<p>Since their discovery, there has been a debate about the actions of chandelier cells (reviewed by Wang and colleagues
<sup><xref ref-type="bibr" rid="ref-98">98</xref></sup>). Some studies using brain slice recordings showed a depolarizing
<sup><xref ref-type="bibr" rid="ref-108">108</xref></sup> and even excitatory
<sup><xref ref-type="bibr" rid="ref-109">109</xref></sup> action for these interneurons, whereas others report an inhibitory action
<sup><xref ref-type="bibr" rid="ref-110">110</xref></sup>. However, chandelier cell membrane potential fluctuations resembling
<italic>in vivo</italic> patterns appear strongly inhibitory
<sup><xref ref-type="bibr" rid="ref-111">111</xref></sup>, and recordings
<italic>in vivo</italic> also suggest an inhibitory role for these interneurons
<sup><xref ref-type="bibr" rid="ref-112">112</xref>,
<xref ref-type="bibr" rid="ref-113">113</xref></sup>.</p>
<p>Whereas patient studies of schizophrenia patients consistently identify both a reduction in the number or length of chandelier cell cartridges
<sup><xref ref-type="bibr" rid="ref-114">114</xref>,
<xref ref-type="bibr" rid="ref-115">115</xref></sup> as well as the misregulation of proteins associated with chandelier cell synapses
<sup><xref ref-type="bibr" rid="ref-12">12</xref>,
<xref ref-type="bibr" rid="ref-116">116</xref>–
<xref ref-type="bibr" rid="ref-118">118</xref></sup>, mouse research on this interneuron class is hampered by the absence of a strategy to specifically target these interneurons. As a result, a limited number of studies focus on chandelier cells but instead report on PV interneurons in general, or PV basket cells, which provide a more accessible target of study because of their relative abundance (
<xref ref-type="fig" rid="f1">Figure 1</xref>). Nonetheless, chandelier cells are considered to play an important role in psychiatric disorders
<sup><xref ref-type="bibr" rid="ref-11">11</xref>,
<xref ref-type="bibr" rid="ref-98">98</xref>,
<xref ref-type="bibr" rid="ref-119">119</xref></sup>, and the development of strategies to specifically target this interneuron subtype would be an important step towards understanding the role of these interneurons.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
<label>Figure 1. </label>
<caption>
<title>Genes linked to psychiatric disorders affect inhibition on different subcellular aspects.</title>
<p>(Left) Genes affecting the input, intrinsic properties or output of chandelier cells. (Right) Genes affecting the input, intrinsic properties or output of parvalbumin-positive (PV) basket cells. (Middle) Genes affecting input, intrinsic properties or output of interneurons, without the interneuron subtype being identified. Pyramidal cells are shown in red, and interneurons are shown in blue.</p>
</caption>
<graphic xlink:href="f1000research-7-13157-g0000"></graphic>
</fig>
<p>Targeting the perisomatic region (basket cells) or AIS (chandelier cells) gives these interneurons strong control over pyramidal cell excitability, and regulation of the synaptic strength of these interneurons is important for normal function of the network. For example, Xue and colleagues have shown that pyramidal neurons receive an amount of synaptic inhibition that is proportional to the amount of synaptic excitation they receive
<sup><xref ref-type="bibr" rid="ref-138">138</xref></sup>, maintaining the E/I balance on the pyramidal cell. Manipulation of pyramidal cell activity leads to a compensatory change in inhibitory drive onto these cells, specifically from PV interneurons
<sup><xref ref-type="bibr" rid="ref-138">138</xref></sup>. In addition, PV interneuron activity is reduced during learning and increased during fear conditioning, and an experimental increase of PV interneuron activity leads to impaired learning
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup>. Apart from synaptic connections, basket cells
<sup><xref ref-type="bibr" rid="ref-139">139</xref></sup> and chandelier cells
<sup><xref ref-type="bibr" rid="ref-111">111</xref>,
<xref ref-type="bibr" rid="ref-140">140</xref></sup> connect via electrical connections, called gap junctions. This electrical coupling synchronizes the interneurons
<sup><xref ref-type="bibr" rid="ref-139">139</xref></sup>, which in turn allows them to synchronize the network
<sup><xref ref-type="bibr" rid="ref-141">141</xref></sup> (for example, in gamma oscillations
<sup><xref ref-type="bibr" rid="ref-142">142</xref></sup>).</p>
<p>Together, these studies indicate that control of the E/I balance by PV interneurons is important for normal network function and that PV interneuron-mediated inhibition can be regulated upon alterations in the network state. Changes in PV interneuron-mediated inhibition would shift the E/I balance and lead to a disruption in network function. Indeed, various parameters affecting inhibitory function of PV cells are consistently found to be altered in psychiatric disorders. In the next section, we focus on studies on animal models of these conditions and discuss how different changes affecting PV cell activity lead to a shift of the E/I balance (
<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
</sec>
<sec>
<title>Altered PV interneuron activity is caused by changes to different subcellular aspects</title>
<p>Alterations to the inhibitory drive, affecting the E/I balance, can arise in different ways. Reduced excitatory input onto interneurons, reduced intrinsic excitability of interneurons, and a reduction in inhibitory synapse number or strength onto pyramidal cells all result in a shift of the E/I balance towards excitation. Indeed, patient and animal studies of psychiatric disorders consistently report changes affecting inhibitory function. A complicating factor in the interpretation of these results comes from the dynamic ability of neuronal networks to adapt to changes, known as homeostatic plasticity. Homeostatic plasticity is the ability of neurons to maintain their levels of excitability within a narrow range and is a constantly active feedback process
<sup><xref ref-type="bibr" rid="ref-143">143</xref></sup>. For example, classic experiments have shown that blocking of action potentials leads to a strengthening of excitatory
<sup><xref ref-type="bibr" rid="ref-144">144</xref></sup> and a weakening of inhibitory synapses
<sup><xref ref-type="bibr" rid="ref-145">145</xref></sup>. Apart from their synaptic input, neurons can regulate their intrinsic excitability
<sup><xref ref-type="bibr" rid="ref-146">146</xref></sup>, which is observed both in excitatory and inhibitory neurons in culture
<sup><xref ref-type="bibr" rid="ref-147">147</xref></sup> and
<italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="ref-148">148</xref></sup>. This means that genetic mutations affecting a specific neuronal property in a specific cell type can trigger homeostatic processes affecting other properties or cell types. In this way, mutations affecting both inhibitory or excitatory cells could ultimately affect inhibitory function
<sup><xref ref-type="bibr" rid="ref-86">86</xref></sup>. It is therefore difficult to distinguish the direct effect of a gene related to a psychiatric disorder from the network adaptation it causes.</p>
<p>Nonetheless, changes to the function of PV interneurons, either direct or indirect, are consistently observed in psychiatric disorders affecting input, output and intrinsic properties, which all lead to an altered inhibitory action of these cells onto their targets (
<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
<sec>
<title>Changes to the input onto PV interneurons</title>
<p>Excitatory inputs onto neurons drive their excitability. Depending on the brain region, PV interneurons receive various types of excitatory input
<sup><xref ref-type="bibr" rid="ref-85">85</xref></sup>, and the amount of excitatory inputs onto PV interneurons is dynamically regulated by behaviour
<sup><xref ref-type="bibr" rid="ref-23">23</xref></sup>. Changes in the amount of excitation onto PV interneurons, altering their activity, have been reported in mouse models of various psychiatric disorders.</p>
<p>The tyrosine kinase receptor ErbB4 has been identified as a risk gene for schizophrenia in genome-wide association studies (GWASs)
<sup><xref ref-type="bibr" rid="ref-149">149</xref>,
<xref ref-type="bibr" rid="ref-150">150</xref></sup>. In the adult mouse, expression of ErbB4 is restricted to interneurons
<sup><xref ref-type="bibr" rid="ref-128">128</xref>,
<xref ref-type="bibr" rid="ref-151">151</xref></sup> and localizes to both the axon terminals
<sup><xref ref-type="bibr" rid="ref-128">128</xref>,
<xref ref-type="bibr" rid="ref-152">152</xref></sup> and post-synaptic densities
<sup><xref ref-type="bibr" rid="ref-128">128</xref>,
<xref ref-type="bibr" rid="ref-151">151</xref></sup>. Selective removal of ErbB4 from PV interneurons causes a reduction in excitatory synapses formed onto both PV basket cells and chandelier cells as well as a reduced number of PV synapses formed on pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-120">120</xref>,
<xref ref-type="bibr" rid="ref-121">121</xref></sup>. This reduced input and output connectivity of PV interneurons is indicative of a reduced inhibitory drive onto pyramidal neurons. As a result of this reduced inhibition of the pyramidal neurons, these neurons become more active, as was seen from the increased frequency of excitatory inputs to both pyramidal neurons and PV interneurons
<sup><xref ref-type="bibr" rid="ref-120">120</xref></sup>. Consequently, recording of the local field potential
<italic>in vivo</italic> revealed a hyperactive network and increased gamma oscillations
<sup><xref ref-type="bibr" rid="ref-120">120</xref></sup>. Single-nucleotide polymorphisms in neuregulin 1 (NRG1), a ligand of ErbB4, have been implicated in schizophrenia
<sup><xref ref-type="bibr" rid="ref-153">153</xref></sup> and bipolar disorder
<sup><xref ref-type="bibr" rid="ref-154">154</xref>,
<xref ref-type="bibr" rid="ref-155">155</xref></sup>. Treatment of neuronal cultures with NRG1, activating ErbB4, leads to an increase in excitatory synapses formed onto interneurons
<sup><xref ref-type="bibr" rid="ref-121">121</xref></sup>. Together, these data show that ErbB4 signalling plays an important role in the regulation of excitatory synapse number onto PV interneurons and that disruption of this system leads to a shift of the E/I balance towards excitation
<sup><xref ref-type="bibr" rid="ref-120">120</xref></sup>.</p>
<p>Also, studies on animal models of ASD have reported postsynaptic changes on PV interneurons. Fragile X syndrome is caused by reduced or absent levels of the RNA-binding protein FMRP, leading to intellectual disability and, in about half of the affected males, ASD
<sup><xref ref-type="bibr" rid="ref-156">156</xref>,
<xref ref-type="bibr" rid="ref-157">157</xref></sup>. While changes to long-term depression on excitatory cells have been the centre of attention for this condition
<sup><xref ref-type="bibr" rid="ref-158">158</xref></sup>, changes to the inhibitory system have consistently been identified
<sup><xref ref-type="bibr" rid="ref-159">159</xref>,
<xref ref-type="bibr" rid="ref-160">160</xref></sup>.
<italic>Fmr1</italic> knockout (KO) mice show a reduced expression of GABAA receptor subunits
<sup><xref ref-type="bibr" rid="ref-161">161</xref></sup> as well as a reduction in the number of PV interneurons
<sup><xref ref-type="bibr" rid="ref-162">162</xref></sup>. In addition, these mice show a marked reduction in local, but not thalamic, excitatory input onto fast-spiking interneurons in layer 4 of the somatosensory cortex, while both the connectivity of fast-spiking interneurons onto pyramidal neurons and excitatory inputs onto pyramidal neurons were unaltered
<sup><xref ref-type="bibr" rid="ref-122">122</xref></sup>. Consistently, the resulting reduced inhibitory drive from fast-spiking interneurons was accompanied by reduced synchrony of gamma oscillations
<sup><xref ref-type="bibr" rid="ref-122">122</xref></sup>. These changes point towards an altered E/I balance towards excitation in fragile X syndrome
<sup><xref ref-type="bibr" rid="ref-163">163</xref></sup>.</p>
<p>Mutations in another gene linked to autism, the transcriptional modulator methyl-CpG-binding protein 2 (
<italic>MECP2</italic>), the causative gene for Rett syndrome
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>, show a similar phenotype. Selective removal of
<italic>Mecp2</italic> from PV cells leads to a specific reduction of local excitatory input, but not thalamocortical input, onto these cells in layer 4 of the visual cortex at post-natal day (P) 30
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. In addition, experimentally evoked PV interneuron input onto pyramidal cells was unaltered
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. Calcium imaging revealed that these synaptic changes lead to a reduced visually evoked, but not spontaneous, activity of PV interneurons
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. Paired recordings at P15 revealed an increased inhibition from PV interneurons through an earlier maturation in
<italic>Mecp2</italic> KO mice
<sup><xref ref-type="bibr" rid="ref-164">164</xref></sup>, and this earlier maturation might influence network development through interference with the normal critical period
<sup><xref ref-type="bibr" rid="ref-164">164</xref>,
<xref ref-type="bibr" rid="ref-165">165</xref></sup>, leading to the changes observed at later ages. This notion is consistent with the recent idea that developmental changes might play an important role in the development of psychiatric symptoms later in life
<sup><xref ref-type="bibr" rid="ref-166">166</xref></sup>. The exact contribution of PV interneurons to the phenotypes observed in Rett syndrome is still unclear. While a general interneuron removal of
<italic>Mecp2</italic> does recapitulate most Rett syndrome phenotypes
<sup><xref ref-type="bibr" rid="ref-167">167</xref></sup>, studies removing
<italic>Mecp2</italic> specifically from PV interneurons have been able to replicate only some of these phenotypes
<sup><xref ref-type="bibr" rid="ref-168">168</xref></sup> or none at all
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. Of note, selective removal of
<italic>Mecp2</italic> from SOM interneurons also recapitulates part of the Rett syndrome phenotypes
<sup><xref ref-type="bibr" rid="ref-168">168</xref></sup>, and selective removal of
<italic>Mecp2</italic> from either PV interneurons or SOM interneurons has been reported to cause circuit-wide deficits in information processing
<sup><xref ref-type="bibr" rid="ref-169">169</xref></sup>. From these studies, a picture is emerging in which excitatory inputs onto PV interneurons are found to be altered in different psychiatric disorders, leading to a reduced activity of these neurons and thereby tilting the E/I balance towards excitation.</p>
</sec>
<sec>
<title>Changes to the intrinsic properties of PV interneurons</title>
<p>The intrinsic properties of neurons are important in translating input into output. Altering these properties allows the neurons to regulate their excitability
<sup><xref ref-type="bibr" rid="ref-170">170</xref>,
<xref ref-type="bibr" rid="ref-171">171</xref></sup>, through which they play an important role in the maintenance of the E/I balance
<sup><xref ref-type="bibr" rid="ref-143">143</xref></sup>. Whereas some of these changes might be causative to psychiatric disorders, others are believed to be compensatory. For example, selective deletion of
<italic>Mecp2</italic> from PV interneurons leads to an increased membrane potential, as well as a hyperpolarized action potential threshold in these cells at P30
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>, but only a slight hyperpolarization of the membrane potential at P15
<sup><xref ref-type="bibr" rid="ref-164">164</xref></sup>. These changes increase the cell’s excitability and are most likely compensatory for the reduced excitatory synaptic input described above
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup> but could still act towards deficits in information processing observed in these animals
<sup><xref ref-type="bibr" rid="ref-169">169</xref></sup>.</p>
<p>Family-based association data have identified dysbindin (
<italic>DTNBP1</italic>) as a susceptibility gene for schizophrenia
<sup><xref ref-type="bibr" rid="ref-172">172</xref></sup>, whose dominant circuit impact is impaired inhibition
<sup><xref ref-type="bibr" rid="ref-173">173</xref></sup>. Dysbindin KO mice show a reduced number of PV interneurons in hippocampal CA1
<sup><xref ref-type="bibr" rid="ref-173">173</xref>,
<xref ref-type="bibr" rid="ref-174">174</xref></sup>, and transcriptome changes of various proteins involved the regulation of intrinsic properties
<sup><xref ref-type="bibr" rid="ref-174">174</xref></sup>. Recordings from PV interneurons in dysbindin KO mice show a reduction in action potential frequency resulting in a reduced inhibitory drive
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>. Interestingly, dopamine D2-receptor expression is increased in these mice, and application of the D2-receptor antagonist quinpirole increases PV interneuron action potential frequency more in dysbindin KO mice than in wild-type mice, suggesting that the changes in action potential frequency are compensatory
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>.</p>
<p>Intrinsic changes can also be the primary cause of psychiatric disorders. Single-gene mutations in
<italic>SCN1A</italic>, encoding the sodium channel Na
<sub>V</sub>1.1α subunit, give rise to Dravet syndrome, a rare genetic epileptic encephalopathy. Patients with Dravet syndrome suffer from epilepsy and have an increased risk for autism
<sup><xref ref-type="bibr" rid="ref-175">175</xref>,
<xref ref-type="bibr" rid="ref-176">176</xref></sup>. Na
<sub>V</sub>1.1 is enriched in the AIS of inhibitory neurons
<sup><xref ref-type="bibr" rid="ref-177">177</xref></sup>, primarily of PV interneurons
<sup><xref ref-type="bibr" rid="ref-91">91</xref></sup>, where axon potentials are initiated
<sup><xref ref-type="bibr" rid="ref-178">178</xref></sup>. Interneurons from
<italic>Scn1a</italic> heterozygous and KO mice show reduced firing frequencies to current injections as well as a reduced action potential amplitude and an increased action potential width, indicating a reduced inhibitory control over downstream targets
<sup><xref ref-type="bibr" rid="ref-127">127</xref></sup>. Removal of
<italic>Scn1a</italic> specifically from forebrain interneurons
<sup><xref ref-type="bibr" rid="ref-179">179</xref></sup> or PV interneurons specifically
<sup><xref ref-type="bibr" rid="ref-180">180</xref></sup> recapitulates phenotypes found in patients. In addition, increasing GABA signalling by application of the positive allosteric GABA
<sub>A</sub> receptor modulator clonazepam was sufficient to rescue the abnormal social behaviour in
<italic>Scn1a</italic>
<sup>+/−</sup> mice
<sup><xref ref-type="bibr" rid="ref-181">181</xref></sup>. These data show that loss of SCN1A primarily affects interneurons and that the consequently reduced inhibitory drive plays an important role in Dravet syndrome.</p>
<p>Recently, a new hypothesis has been proposed in the field of schizophrenia, focussing on the myelination of PV interneurons as a point of pathological convergence
<sup><xref ref-type="bibr" rid="ref-182">182</xref></sup>. As discussed above, PV cells play a central role in schizophrenia. Myelination abnormalities, including white matter abnormalities
<sup><xref ref-type="bibr" rid="ref-183">183</xref></sup>, reduced numbers of oligodendrocytes
<sup><xref ref-type="bibr" rid="ref-184">184</xref></sup> and post-mortem gene expression analysis
<sup><xref ref-type="bibr" rid="ref-185">185</xref></sup>, have been identified in schizophrenia. Myelination of PV interneurons has been observed in rats
<sup><xref ref-type="bibr" rid="ref-186">186</xref></sup>, mice
<sup><xref ref-type="bibr" rid="ref-187">187</xref></sup> and post-mortem in humans
<sup><xref ref-type="bibr" rid="ref-188">188</xref></sup>. Myelination is important for fast action potential propagation
<sup><xref ref-type="bibr" rid="ref-189">189</xref></sup>, and deficits in the myelination of PV interneurons are proposed to disrupt inhibitory network function
<sup><xref ref-type="bibr" rid="ref-182">182</xref></sup>. However, this appealing hypothesis remains to be experimentally tested.</p>
</sec>
</sec>
<sec>
<title>Changes to synapses formed by PV interneurons</title>
<p>Changes to PV synapses are abundantly studied and identified in various conditions. Post-mortem studies of schizophrenia patients consistently identify changes to the cartridges formed by chandelier cells, showing a decrease in pre-synaptic GAT1 expression
<sup><xref ref-type="bibr" rid="ref-116">116</xref>,
<xref ref-type="bibr" rid="ref-117">117</xref></sup> and an increase in the expression of post-synaptic GABAAα2
<sup><xref ref-type="bibr" rid="ref-118">118</xref></sup>. These changes would lead to an increased inhibitory drive from chandelier cells and are believed to be compensatory for a reduced activity of these cells, as indicated by reduced levels of GAD67 in PV cells
<sup><xref ref-type="bibr" rid="ref-190">190</xref></sup>. In addition, a recent study shows a reduction in the density of a specific type a cartridges, calbindin-positive cartridges, in schizophrenia
<sup><xref ref-type="bibr" rid="ref-114">114</xref></sup>.</p>
<p>Besides changes in the input to PV interneurons, mutations in
<italic>Erbb4</italic> also lead to a reduction in synapses formed by PV interneurons on pyramidal neurons, specifically from chandelier cells
<sup><xref ref-type="bibr" rid="ref-120">120</xref>,
<xref ref-type="bibr" rid="ref-128">128</xref></sup>. In addition, overexpression of
<italic>Nrg1</italic>, the ligand for ErbB4, in pyramidal neurons increases bouton density on both the AIS and the soma of pyramidal neurons. The increase in bouton density on the AIS originates from chandelier cells since only these cells target the AIS. The origin of the increase in perisomatic bouton density is not clear since a recent report has shown that synapses formed by cholecystokinin (CCK) basket cells require ErbB4 function to form perisomatic synapses
<sup><xref ref-type="bibr" rid="ref-191">191</xref></sup>. Future research should unveil whether the increase in perisomatic boutons density arises from PV or CCK basket cells.</p>
<p>Tuberous sclerosis is a disorder whose symptoms include epilepsy and autism
<sup><xref ref-type="bibr" rid="ref-192">192</xref></sup>. Loss-of-function mutations in the mammalian target of rapamycin (mTOR)-negative regulators TSC1 or TSC2 underlie this condition
<sup><xref ref-type="bibr" rid="ref-193">193</xref></sup>. Slice recordings from
<italic>TSC1</italic> KO neurons revealed a reduced inhibitory drive onto CA1 pyramidal neurons, while excitatory input was unaltered
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>.
<italic>TSC1</italic> KO neurons were created by sparsely targeting neurons in a conditional TSC1 KO mouse with a cre-expressing adeno-associated virus
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>. The finding that sparse KO of TSC1 leads to a similar phenotype as in neurons from full KO animals indicates that these results are cell-autonomous rather than compensatory
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>.</p>
<p>Angelman syndrome, caused by loss-of-function mutations or deletion of E3 ubiquitin ligase
<italic>UBE3A</italic>
<sup><xref ref-type="bibr" rid="ref-194">194</xref></sup>, is characterized by epilepsy and autism
<sup><xref ref-type="bibr" rid="ref-195">195</xref>,
<xref ref-type="bibr" rid="ref-196">196</xref></sup>. Mouse models for Angelman syndrome recapitulate human phenotypes
<sup><xref ref-type="bibr" rid="ref-197">197</xref></sup> and initially were found to show a reduced excitatory drive onto pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-198">198</xref></sup>. However, inhibitory input was also found to be decreased, caused by defects in synaptic vesicle cycling
<sup><xref ref-type="bibr" rid="ref-130">130</xref></sup>. It was hypothesized that the reduced inhibition could outweigh the reduced excitation, leading to the epilepsy and autism phenotypes obeserved
<sup><xref ref-type="bibr" rid="ref-130">130</xref>,
<xref ref-type="bibr" rid="ref-199">199</xref></sup>. Consistent with this idea, a recent study using
<italic>in vivo</italic> whole cell recordings shows that pyramidal neurons in
<italic>Ube3a</italic> KO mice display decreased orientation selectivity
<sup><xref ref-type="bibr" rid="ref-200">200</xref></sup>, indicative of reduced inhibition
<sup><xref ref-type="bibr" rid="ref-201">201</xref>,
<xref ref-type="bibr" rid="ref-202">202</xref></sup>. However, these mice also show increased excitability of pyramidal neurons, which is non–cell-autonomous, suggesting that pyramidal neurons homeostatically increase their excitability because of a relative decrease of excitation
<sup><xref ref-type="bibr" rid="ref-200">200</xref></sup>. While it is unclear whether reduced inhibition or reduced excitation has a stronger impact on pyramidal neurons in Angelman syndrome, the change in their relative contribution, resulting in an altered E/I balance, seems to play a pivotal role in this condition.</p>
<p>Single
<italic>SHANK3</italic> mutations, at the level of point mutations or microdeletions, have been identified in patients with ASD
<sup><xref ref-type="bibr" rid="ref-203">203</xref></sup>. In the human genome, there are three SHANK genes (
<italic>SHANK1-3</italic>), which all code for scaffold proteins located at the postsynaptic density of excitatory synapses, of which SHANK3 is best studied
<sup><xref ref-type="bibr" rid="ref-204">204</xref>–
<xref ref-type="bibr" rid="ref-206">206</xref></sup>. Because of this localisation, most studies have focussed on excitatory synapses, where
<italic>Shank3</italic>-deficient mice show reduced cortico-striatal connectivity
<sup><xref ref-type="bibr" rid="ref-207">207</xref></sup>, impaired long-term potentiation
<sup><xref ref-type="bibr" rid="ref-208">208</xref></sup> and reduced GluA1 expression
<sup><xref ref-type="bibr" rid="ref-209">209</xref></sup>. Recent studies, however, indicate that the inhibitory system is also affected.
<italic>Shank3</italic> mutant mice lacking exon 9 show reduced inhibitory input onto layer 2/3 pyramidal neurons but an increase of these events in CA1 pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-131">131</xref></sup>. In addition, PV levels are reduced in
<italic>Shank1</italic> KO and
<italic>Shank3b</italic> KO mice, indicating reduced activity
<sup><xref ref-type="bibr" rid="ref-22">22</xref></sup>.</p>
<p>Presynaptic neurexins and their postsynaptic partners neuroligins are a large class of cell-adhesion molecules that have been shown to play important roles in synaptic specificity
<sup><xref ref-type="bibr" rid="ref-210">210</xref></sup>. Overexpression or knockdown of neuroligins leads to an increase or decrease in synapse number, respectively
<sup><xref ref-type="bibr" rid="ref-211">211</xref></sup>. Neuroligins are expressed at specific synapses: neuroligin
<italic></italic> 1 (NLGN1) is mainly expressed at excitatory synapses
<sup><xref ref-type="bibr" rid="ref-212">212</xref></sup>, NLGN2 is expressed at inhibitory synapses
<sup><xref ref-type="bibr" rid="ref-213">213</xref></sup>, NLGN3
<italic></italic> is expressed at both inhibitory and excitatory synapses
<sup><xref ref-type="bibr" rid="ref-214">214</xref></sup> and NLGN4
<italic></italic> is expressed at glycinergic synapses
<sup><xref ref-type="bibr" rid="ref-215">215</xref></sup>. Mutations and deletions affecting human
<italic>NLGN3</italic>, including a gain-of-function mutation, and
<italic>NLGN4 de novo</italic> mutations have been found in Swedish families and have been associated with autism
<sup><xref ref-type="bibr" rid="ref-216">216</xref></sup>.
<italic>Nlgn3</italic> deletion in mice leads to increased inhibitory transmission onto pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-217">217</xref></sup>, specifically from CCK-positive interneurons because of an increased tonic endocannabinoid signalling, whereas PV interneuron connectivity is unaffected
<sup><xref ref-type="bibr" rid="ref-136">136</xref></sup>. A recent study, however, has shown that conditional deletion of
<italic>Ngln3</italic> from PV interneurons alters AMPA/NMDA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/N-methyl-d-aspartate) ratio of excitatory input onto these cells and causes reduced gamma oscillations
<sup><xref ref-type="bibr" rid="ref-124">124</xref></sup>. In addition to the loss of
<italic>NLGN3</italic>, a gain-of-function amino acid substitution (R451C) in
<italic>NLGN3</italic> is associated with autism
<sup><xref ref-type="bibr" rid="ref-216">216</xref></sup>. Mice carrying this mutation show a strong reduction in inhibitory drive from PV interneurons while increasing the inhibitory drive from CCK cells
<sup><xref ref-type="bibr" rid="ref-136">136</xref></sup>.</p>
<p>
<italic>Nlgn4</italic> KO mice show a reduced number of perisomatic inhibitory synapses in hippocampus and a concomitant reduction in inhibitory input
<sup><xref ref-type="bibr" rid="ref-218">218</xref></sup>. In addition, a reduced power of evoked gamma oscillations in acute slices was observed
<sup><xref ref-type="bibr" rid="ref-218">218</xref></sup>. Different mutations in
<italic>NLGN2</italic> have been linked to autism
<sup><xref ref-type="bibr" rid="ref-219">219</xref></sup> and schizophrenia
<sup><xref ref-type="bibr" rid="ref-220">220</xref></sup>. Deletion of
<italic>Nlgn2</italic> has been shown to specifically reduce the amount of perisomatic synapses on pyramidal neurons in hippocampus
<sup><xref ref-type="bibr" rid="ref-135">135</xref></sup> and reduce inhibitory transmission from PV interneurons but not SOM interneurons
<sup><xref ref-type="bibr" rid="ref-134">134</xref></sup>.</p>
<p>Neurexins are less well studied in the context of psychiatric disorders. There are three neurexin genes, each coding for an α- and β-neurexin. Mutations in neurexin (
<italic>NRXN1</italic>) have been associated with autism
<sup><xref ref-type="bibr" rid="ref-221">221</xref></sup> and schizophrenia, affecting both
<italic>NRXN1α</italic> and
<italic>NRXN1β</italic>
<sup><xref ref-type="bibr" rid="ref-222">222</xref>,
<xref ref-type="bibr" rid="ref-223">223</xref></sup>.
<italic>Nrxn1α</italic> KO mice do not show changes in inhibitory drive but do show a reduced excitatory drive onto CA1 pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-224">224</xref></sup>. However, mice carrying mutations in
<italic>Nrxn1β</italic> show a reduced frequency of both inhibitory and excitatory input onto cortical pyramidal neurons
<sup><xref ref-type="bibr" rid="ref-225">225</xref></sup> suggestive of a reduced number of synaptic contacts. These studies show that neuroligin and neurexin mutations that are linked to autism affect the inhibitory system, including perisomatic-targeting interneurons.</p>
<p>Studies of ADHD rodent models have mainly focussed on the dopamine system and excitatory synapses
<sup><xref ref-type="bibr" rid="ref-226">226</xref></sup>. However, recent studies identify changes to inhibitory connectivity. G protein–coupled receptor kinase interacting protein 1 (GIT1) has been identified by a GWAS as a risk gene for ADHD
<sup><xref ref-type="bibr" rid="ref-132">132</xref></sup>, but recent studies challenge this claim
<sup><xref ref-type="bibr" rid="ref-227">227</xref>,
<xref ref-type="bibr" rid="ref-228">228</xref></sup>.
<italic>Git1</italic> KO mice show ADHD-like phenotypes, including hyperactivity
<sup><xref ref-type="bibr" rid="ref-132">132</xref></sup>. While excitatory input to CA1 pyramidal neurons remains unaltered, the frequency of inhibitory inputs is reduced, suggesting a reduction of inhibitory synaptic contacts
<sup><xref ref-type="bibr" rid="ref-132">132</xref></sup>, consistent with previous studies showing a role for GIT1 in inhibitory synapses
<sup><xref ref-type="bibr" rid="ref-229">229</xref></sup>. In addition, PV expression was reduced while other interneuron markers remained unaltered
<sup><xref ref-type="bibr" rid="ref-132">132</xref></sup>.</p>
<p>Another ADHD-linked gene identified by GWASs, cadherin 13 (
<italic>CDH13</italic>)
<sup><xref ref-type="bibr" rid="ref-230">230</xref>–
<xref ref-type="bibr" rid="ref-232">232</xref></sup>, is exclusively expressed in inhibitory neurons
<sup><xref ref-type="bibr" rid="ref-133">133</xref></sup>.
<italic>Cdh13</italic> KO mice show an increase in inhibitory synaptic contacts onto CA1 pyramidal neurons, while excitatory inputs remained unaltered
<sup><xref ref-type="bibr" rid="ref-133">133</xref></sup>. This increase in inhibitory synaptic contacts could underlie the increase in gamma oscillations observed in ADHD patients discussed before
<sup><xref ref-type="bibr" rid="ref-59">59</xref>–
<xref ref-type="bibr" rid="ref-62">62</xref></sup>.
<italic>Cdh13</italic> KO mice show a reduced number of interneurons at embryonic day 18.5
<sup><xref ref-type="bibr" rid="ref-233">233</xref></sup> but not at P21
<sup><xref ref-type="bibr" rid="ref-133">133</xref></sup>. Experiments are needed to test whether the changes in interneuron number have a role in the aetiology of ADHD.</p>
<p>In addition to changes in the number and strength of inhibitory synapses, changes are found in the modulation of inhibitory synaptic transmission. Metabotropic GABA receptors, GABA
<sub>B</sub> receptors, are expressed both pre- and postsynaptically in GABAergic synapses
<sup><xref ref-type="bibr" rid="ref-234">234</xref></sup>. Postsynaptic GABA
<sub>B</sub> receptors activate potassium channels that hyperpolarize the postsynaptic cell
<sup><xref ref-type="bibr" rid="ref-235">235</xref></sup>. Presynaptic GABA
<sub>B</sub> receptors, in addition, can reduce calcium inflow and reduce neurotransmitter release
<sup><xref ref-type="bibr" rid="ref-236">236</xref>,
<xref ref-type="bibr" rid="ref-237">237</xref></sup>. A reduction of GABA
<sub>B</sub> subunit expression has been observed in post-mortem studies of patients with schizophrenia
<sup><xref ref-type="bibr" rid="ref-238">238</xref>,
<xref ref-type="bibr" rid="ref-239">239</xref></sup>, patients with bipolar disorder
<sup><xref ref-type="bibr" rid="ref-240">240</xref></sup> and patients with major depression
<sup><xref ref-type="bibr" rid="ref-241">241</xref></sup> as well as animal models for schizophrenia
<sup><xref ref-type="bibr" rid="ref-242">242</xref>–
<xref ref-type="bibr" rid="ref-244">244</xref></sup>. However, more research is required to identify the exact role for GABA
<sub>B</sub> receptors in psychiatric disorders.</p>
<p>In summary, changes to the inhibitory drive of PV interneurons can be caused by changes affecting the input, output or intrinsic properties of PV interneurons, and animal models of various psychiatric disorders all show alterations to one or more of these aspects, tilting the E/I balance.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusions</title>
<p>Psychiatric disorders are a diverse group of disorders, but changes to the inhibitory system seem to be a point of convergence. Impairment of normal inhibitory function can arise from input to, output from, or intrinsic properties of inhibitory neurons. Altered inhibitory activity or drive leads to changes in signal processing, which in turn is believed to underlie the phenotypic changes observed in the various psychiatric disorders. PV-positive interneurons play a pivotal role in these conditions, possibly through their strong inhibitory effect on pyramidal cell activity due to the axonal or perisomatic targeting of their axons in combination with the nature of their functions in the network.</p>
<p>Changes to either excitation or inhibition will change the ratio between these two types of input, leading to a change in the E/I balance. The examples described above indicate that various psychiatric disorders occur following changes to the input, output or intrinsic properties of specific interneurons, PV interneurons, leading to an altered activity of these neurons. It seems from the studies discussed that specific changes in the E/I balance lead to a disruption of specific function(s) in the network that affect signal processing in a specific way to result in a specific psychiatric phenotype. This might explain why different disorders present different phenotypes, in both patients and animal studies. For example, changes in chandelier cell cartridges seem to be more prominent in schizophrenia. However, other factors are likely to contribute to the development of a specific disorder. Apart from the affected PV cell type, the direction of the altered activity (increased/decreased E/I balance) might be an important factor. Another interesting aspect might be the changes in interneuron-interneuron connectivity, which could lead to altered signal integration and network activity. Some genes have been associated with multiple psychiatric disorders, indicating that a mutation does not in all cases lead to a specific condition. Individual difference in compensatory plasticity could subtly affect network development, steering the developing network towards a specific disorder. It should be noted that while homeostatic changes might compensate a specific alteration, this compensation might disrupt other pathways. While the above-mentioned factors potentially all play a role in the development of specific psychiatric disorders, more research is needed to identify how specific alterations to PV interneurons affect network processing and behaviour.</p>
<p>The notion that psychiatric disorders are caused by changes to the inhibitory drive from PV interneurons means that a restoration of this drive could improve patient symptoms. An interesting possibility of counteracting the changes to the inhibitory system would be to make use of the neuron’s ability for homeostatic plasticity
<sup><xref ref-type="bibr" rid="ref-170">170</xref></sup>. Homeostatic mechanisms function to keep neurons in an optimal range of activity
<sup><xref ref-type="bibr" rid="ref-245">245</xref></sup>. Understanding which genetic and molecular mechanisms underlie these homeostatic processes opens the possibility to ‘hijack’ these pathways and manipulate the neuron’s activity in a way to compensate for the altered inhibitory drive. In this way, it might be possible to selectively up- or downregulate the activity levels of specific interneuron populations and thereby ameliorate the symptoms observed in patients with the various disorders.</p>
<p>While psychiatric disorders are still far from being fully understood, the study of the role of the inhibitory system in these conditions might further increase our understanding of both the diseased and the healthy brain and hopefully could lead to treatment or alleviation of the symptoms for those suffering from these conditions.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Wei Ba and Clémence Bernard for valuable discussions.</p>
</ack>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gore</surname><given-names>FM</given-names></name><name><surname>Bloem</surname><given-names>PJ</given-names></name><name><surname>Patton</surname><given-names>GC</given-names></name><etal></etal></person-group>:
<article-title>Global burden of disease in young people aged 10–24 years: a systematic analysis.</article-title>
<source/><italic>Lancet.</italic>
<year>2011</year>;<volume>377</volume>(<issue>9783</issue>):<fpage>2093</fpage>–<lpage>102</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(11)60512-6</pub-id>
<pub-id pub-id-type="pmid">21652063</pub-id></mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>FS</given-names></name><name><surname>Heimer</surname><given-names>H</given-names></name><name><surname>Giedd</surname><given-names>JN</given-names></name><etal></etal></person-group>:
<article-title>Mental health. Adolescent mental health--opportunity and obligation.</article-title>
<source/><italic>Science.</italic>
<year>2014</year>;<volume>346</volume>(<issue>6209</issue>):<fpage>547</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1260497</pub-id>
<!--<pub-id pub-id-type="pmcid">5069680</pub-id>-->
<pub-id pub-id-type="pmid">25359951</pub-id></mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elsabbagh</surname><given-names>M</given-names></name><name><surname>Divan</surname><given-names>G</given-names></name><name><surname>Koh</surname><given-names>YJ</given-names></name><etal></etal></person-group>:
<article-title>Global prevalence of autism and other pervasive developmental disorders.</article-title>
<source/><italic>Autism Res.</italic>
<year>2012</year>;<volume>5</volume>(<issue>3</issue>):<fpage>160</fpage>–<lpage>79</lpage>.
<pub-id pub-id-type="doi">10.1002/aur.239</pub-id>
<!--<pub-id pub-id-type="pmcid">3763210</pub-id>-->
<pub-id pub-id-type="pmid">22495912</pub-id></mixed-citation>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Remington</surname><given-names>G</given-names></name><name><surname>Foussias</surname><given-names>G</given-names></name><name><surname>Fervaha</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Treating Negative Symptoms in Schizophrenia: an Update.</article-title>
<source/><italic>Curr Treat Options Psychiatry.</italic>
<year>2016</year>;<volume>3</volume>(<issue>2</issue>):<fpage>133</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1007/s40501-016-0075-8</pub-id>
<!--<pub-id pub-id-type="pmcid">4908169</pub-id>-->
<pub-id pub-id-type="pmid">27376016</pub-id></mixed-citation>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doyle</surname><given-names>CA</given-names></name><name><surname>McDougle</surname><given-names>CJ</given-names></name></person-group>:
<article-title>Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.</article-title>
<source/><italic>Dialogues Clin Neurosci.</italic>
<year>2012</year>;<volume>14</volume>(<issue>3</issue>):<fpage>263</fpage>–<lpage>79</lpage>.
<!--<pub-id pub-id-type="pmcid">3513681</pub-id>-->
<pub-id pub-id-type="pmid">23226952</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Os</surname><given-names>J</given-names></name><name><surname>Kapur</surname><given-names>S</given-names></name></person-group>:
<article-title>Schizophrenia.</article-title>
<source/><italic>Lancet.</italic>
<year>2009</year>;<volume>374</volume>(<issue>9690</issue>):<fpage>635</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(09)60995-8</pub-id>
<pub-id pub-id-type="pmid">19700006</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Merzenich</surname><given-names>MM</given-names></name></person-group>:
<article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<year>2003</year>;<volume>2</volume>(<issue>5</issue>):<fpage>255</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id>
<pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725882229">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Penzes</surname><given-names>P</given-names></name></person-group>:
<article-title>Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.</article-title>
<source/><italic>Curr Mol Med.</italic>
<year>2015</year>;<volume>15</volume>(<issue>2</issue>):<fpage>146</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.2174/1566524015666150303003028</pub-id>
<!--<pub-id pub-id-type="pmcid">4721588</pub-id>-->
<pub-id pub-id-type="pmid">25732149</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canitano</surname><given-names>R</given-names></name><name><surname>Pallagrosi</surname><given-names>M</given-names></name></person-group>:
<article-title>Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories.</article-title>
<source/><italic>Front Psychiatry.</italic>
<year>2017</year>;<volume>8</volume>:<fpage>69</fpage>.
<pub-id pub-id-type="doi">10.3389/fpsyt.2017.00069</pub-id>
<!--<pub-id pub-id-type="pmcid">5410649</pub-id>-->
<pub-id pub-id-type="pmid">28507523</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marín</surname><given-names>O</given-names></name></person-group>:
<article-title>Interneuron dysfunction in psychiatric disorders.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2012</year>;<volume>13</volume>(<issue>2</issue>):<fpage>107</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn3155</pub-id>
<pub-id pub-id-type="pmid">22251963</pub-id></mixed-citation>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Volk</surname><given-names>DW</given-names></name></person-group>:
<article-title>Cortical inhibitory neurons and schizophrenia.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2005</year>;<volume>6</volume>(<issue>4</issue>):<fpage>312</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn1648</pub-id>
<pub-id pub-id-type="pmid">15803162</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1025047">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Curley</surname><given-names>AA</given-names></name><name><surname>Glausier</surname><given-names>JR</given-names></name><etal></etal></person-group>:
<article-title>Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.</article-title>
<source/><italic>Trends Neurosci.</italic>
<year>2012</year>;<volume>35</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1016/j.tins.2011.10.004</pub-id>
<!--<pub-id pub-id-type="pmcid">3253230</pub-id>-->
<pub-id pub-id-type="pmid">22154068</pub-id></mixed-citation>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><etal></etal></person-group>:
<article-title>GABA
<sub>A</sub> receptor downregulation in brains of subjects with autism.</article-title>
<source/><italic>J Autism Dev Disord.</italic>
<year>2009</year>;<volume>39</volume>(<issue>2</issue>):<fpage>223</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1007/s10803-008-0646-7</pub-id>
<!--<pub-id pub-id-type="pmcid">2697059</pub-id>-->
<pub-id pub-id-type="pmid">18821008</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726988471">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Halt</surname><given-names>AR</given-names></name><name><surname>Stary</surname><given-names>JM</given-names></name><etal></etal></person-group>:
<article-title>Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.</article-title>
<source/><italic>Biol Psychiatry.</italic>
<year>2002</year>;<volume>52</volume>(<issue>8</issue>):<fpage>805</fpage>–<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.1016/S0006-3223(02)01430-0</pub-id>
<pub-id pub-id-type="pmid">12372652</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beasley</surname><given-names>CL</given-names></name><name><surname>Reynolds</surname><given-names>GP</given-names></name></person-group>:
<article-title>Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.</article-title>
<source/><italic>Schizophr Res.</italic>
<year>1997</year>;<volume>24</volume>(<issue>3</issue>):<fpage>349</fpage>–<lpage>55</lpage>.
<pub-id pub-id-type="doi">10.1016/S0920-9964(96)00122-3</pub-id>
<pub-id pub-id-type="pmid">9134596</pub-id></mixed-citation>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beasley</surname><given-names>CL</given-names></name><name><surname>Zhang</surname><given-names>ZJ</given-names></name><name><surname>Patten</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.</article-title>
<source/><italic>Biol Psychiatry.</italic>
<year>2002</year>;<volume>52</volume>(<issue>7</issue>):<fpage>708</fpage>–<lpage>15</lpage>.
<pub-id pub-id-type="doi">10.1016/S0006-3223(02)01360-4</pub-id>
<pub-id pub-id-type="pmid">12372661</pub-id></mixed-citation>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Oshima</surname><given-names>A</given-names></name><name><surname>Nozaki</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.</article-title>
<source/><italic>Neuropathology.</italic>
<year>2008</year>;<volume>28</volume>(<issue>2</issue>):<fpage>143</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1440-1789.2007.00867.x</pub-id>
<pub-id pub-id-type="pmid">18069969</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fung</surname><given-names>SJ</given-names></name><name><surname>Webster</surname><given-names>MJ</given-names></name><name><surname>Sivagnanasundaram</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia.</article-title>
<source/><italic>Am J Psychiatry.</italic>
<year>2010</year>;<volume>167</volume>(<issue>12</issue>):<fpage>1479</fpage>–<lpage>88</lpage>.
<pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09060784</pub-id>
<pub-id pub-id-type="pmid">21041246</pub-id></mixed-citation>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selemon</surname><given-names>LD</given-names></name><name><surname>Zecevic</surname><given-names>N</given-names></name></person-group>:
<article-title>Schizophrenia: a tale of two critical periods for prefrontal cortical development.</article-title>
<source/><italic>Transl Psychiatry.</italic>
<year>2015</year>;<volume>5</volume>:<fpage>e623</fpage>.
<pub-id pub-id-type="doi">10.1038/tp.2015.115</pub-id>
<!--<pub-id pub-id-type="pmcid">4564568</pub-id>-->
<pub-id pub-id-type="pmid">26285133</pub-id></mixed-citation>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Volk</surname><given-names>DW</given-names></name><name><surname>Eggan</surname><given-names>SM</given-names></name><etal></etal></person-group>:
<article-title>Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2003</year>;<volume>23</volume>(<issue>15</issue>):<fpage>6315</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="pmid">12867516</pub-id></mixed-citation>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Enwright</surname><given-names>JF</given-names></name><name><surname>Sanapala</surname><given-names>S</given-names></name><name><surname>Foglio</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia.</article-title>
<source/><italic>Neuropsychopharmacology.</italic>
<year>2016</year>;<volume>41</volume>(<issue>9</issue>):<fpage>2206</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1038/npp.2016.24</pub-id>
<!--<pub-id pub-id-type="pmcid">4946056</pub-id>-->
<pub-id pub-id-type="pmid">26868058</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726140683">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Filice</surname><given-names>F</given-names></name><name><surname>Vörckel</surname><given-names>KJ</given-names></name><name><surname>Sungur</surname><given-names>AÖ</given-names></name><etal></etal></person-group>:
<article-title>Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism.</article-title>
<source/><italic>Mol Brain.</italic>
<year>2016</year>;<volume>9</volume>(<issue>10</issue>):<fpage>10</fpage>.
<pub-id pub-id-type="doi">10.1186/s13041-016-0192-8</pub-id>
<!--<pub-id pub-id-type="pmcid">4729132</pub-id>-->
<pub-id pub-id-type="pmid">26819149</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726107089">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Donato</surname><given-names>F</given-names></name><name><surname>Rompani</surname><given-names>SB</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group>:
<article-title>Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning.</article-title>
<source/><italic>Nature.</italic>
<year>2013</year>;<volume>504</volume>(<issue>7479</issue>):<fpage>272</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12866</pub-id>
<pub-id pub-id-type="pmid">24336286</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718206658">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Philpot</surname><given-names>BD</given-names></name><name><surname>Lim</surname><given-names>JH</given-names></name><name><surname>Brunjes</surname><given-names>PC</given-names></name></person-group>:
<article-title>Activity-dependent regulation of calcium-binding proteins in the developing rat olfactory bulb.</article-title>
<source/><italic>J Comp Neurol.</italic>
<year>1997</year>;<volume>387</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19971013)387:1&lt;12::AID-CNE2&gt;3.0.CO;2-Q</pub-id>
<pub-id pub-id-type="pmid">9331168</pub-id></mixed-citation>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanno-Iijima</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Iijima</surname><given-names>T</given-names></name></person-group>:
<article-title>Activity-Dependent Bidirectional Regulation of GAD Expression in a Homeostatic Fashion Is Mediated by BDNF-Dependent and Independent Pathways.</article-title>
<source/><italic>PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0134296</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0134296</pub-id>
<!--<pub-id pub-id-type="pmcid">4524701</pub-id>-->
<pub-id pub-id-type="pmid">26241953</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725695976">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fung</surname><given-names>SJ</given-names></name><name><surname>Fillman</surname><given-names>SG</given-names></name><name><surname>Webster</surname><given-names>MJ</given-names></name><etal></etal></person-group>:
<article-title>Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers.</article-title>
<source/><italic>Schizophr Res.</italic>
<year>2014</year>;<volume>155</volume>(<issue>1–3</issue>):<fpage>26</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1016/j.schres.2014.02.021</pub-id>
<pub-id pub-id-type="pmid">24674775</pub-id></mixed-citation>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klempan</surname><given-names>TA</given-names></name><name><surname>Sequeira</surname><given-names>A</given-names></name><name><surname>Canetti</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.</article-title>
<source/><italic>Mol Psychiatry.</italic>
<year>2009</year>;<volume>14</volume>(<issue>2</issue>):<fpage>175</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1038/sj.mp.4002110</pub-id>
<pub-id pub-id-type="pmid">17938633</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luscher</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Sahir</surname><given-names>N</given-names></name></person-group>:
<article-title>The GABAergic deficit hypothesis of major depressive disorder.</article-title>
<source/><italic>Mol Psychiatry.</italic>
<year>2011</year>;<volume>16</volume>(<issue>4</issue>):<fpage>383</fpage>–<lpage>406</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2010.120</pub-id>
<!--<pub-id pub-id-type="pmcid">3412149</pub-id>-->
<pub-id pub-id-type="pmid">21079608</pub-id></mixed-citation>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>A</given-names></name><name><surname>Auta</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><etal></etal></person-group>:
<article-title>Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.</article-title>
<source/><italic>Arch Gen Psychiatry.</italic>
<year>2000</year>;<volume>57</volume>(<issue>11</issue>):<fpage>1061</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1001/archpsyc.57.11.1061</pub-id>
<pub-id pub-id-type="pmid">11074872</pub-id></mixed-citation>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Fukata</surname><given-names>M</given-names></name></person-group>:
<article-title>Epilepsy and synaptic proteins.</article-title>
<source/><italic>Curr Opin Neurobiol.</italic>
<year>2017</year>;<volume>45</volume>(<issue>1–8</issue>):<fpage>1</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2017.02.001</pub-id>
<pub-id pub-id-type="pmid">28219682</pub-id></mixed-citation>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Treiman</surname><given-names>DM</given-names></name></person-group>:
<article-title>GABAergic mechanisms in epilepsy.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2001</year>;<volume>42</volume>(<issue>Suppl 3</issue>):<fpage>8</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1046/j.1528-1157.2001.042suppl.3008.x</pub-id>
<pub-id pub-id-type="pmid">11520315</pub-id></mixed-citation>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Symonds</surname><given-names>C</given-names></name></person-group>:
<article-title>Excitation and inhibition in epilepsy.</article-title>
<source/><italic>Proc R Soc Med.</italic>
<year>1959</year>;<volume>52</volume>(<issue>6</issue>):<fpage>395</fpage>–<lpage>402</lpage>.
<!--<pub-id pub-id-type="pmcid">1871143</pub-id>-->
<pub-id pub-id-type="pmid">13667910</pub-id></mixed-citation>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wong</surname><given-names>M</given-names></name></person-group>:
<article-title>Too much inhibition leads to excitation in absence epilepsy.</article-title>
<source/><italic>Epilepsy Curr.</italic>
<year>2010</year>;<volume>10</volume>(<issue>5</issue>):<fpage>131</fpage>–<lpage>2</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1535-7511.2010.01379.x</pub-id>
<!--<pub-id pub-id-type="pmcid">2951695</pub-id>-->
<pub-id pub-id-type="pmid">20944826</pub-id></mixed-citation>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bolton</surname><given-names>PF</given-names></name><name><surname>Carcani-Rathwell</surname><given-names>I</given-names></name><name><surname>Hutton</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Epilepsy in autism: features and correlates.</article-title>
<source/><italic>Br J Psychiatry.</italic>
<year>2011</year>;<volume>198</volume>(<issue>4</issue>):<fpage>289</fpage>–<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1192/bjp.bp.109.076877</pub-id>
<!--<pub-id pub-id-type="pmcid">3065774</pub-id>-->
<pub-id pub-id-type="pmid">21972278</pub-id></mixed-citation>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tuchman</surname><given-names>R</given-names></name><name><surname>Moshé</surname><given-names>SL</given-names></name><name><surname>Rapin</surname><given-names>I</given-names></name></person-group>:
<article-title>Convulsing toward the pathophysiology of autism.</article-title>
<source/><italic>Brain Dev.</italic>
<year>2009</year>;<volume>31</volume>(<issue>2</issue>):<fpage>95</fpage>–<lpage>103</lpage>.
<pub-id pub-id-type="doi">10.1016/j.braindev.2008.09.009</pub-id>
<!--<pub-id pub-id-type="pmcid">2734903</pub-id>-->
<pub-id pub-id-type="pmid">19006654</pub-id></mixed-citation>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jian</surname><given-names>L</given-names></name><name><surname>Nagarajan</surname><given-names>L</given-names></name><name><surname>de Klerk</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Predictors of seizure onset in Rett syndrome.</article-title>
<source/><italic>J Pediatr.</italic>
<year>2006</year>;<volume>149</volume>(<issue>4</issue>):<fpage>542</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jpeds.2006.06.015</pub-id>
<pub-id pub-id-type="pmid">17011329</pub-id></mixed-citation>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amir</surname><given-names>RE</given-names></name><name><surname>Van den Veyver</surname><given-names>IB</given-names></name><name><surname>Wan</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.</article-title>
<source/><italic>Nat Genet.</italic>
<year>1999</year>;<volume>23</volume>(<issue>2</issue>):<fpage>185</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gelisse</surname><given-names>P</given-names></name><name><surname>Samuelian</surname><given-names>JC</given-names></name><name><surname>Genton</surname><given-names>P</given-names></name></person-group>:
<article-title>Is schizophrenia a risk factor for epilepsy or acute symptomatic seizures?</article-title>
<source/><italic>Epilepsia.</italic>
<year>1999</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1566</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1999.tb02041.x</pub-id>
<pub-id pub-id-type="pmid">10565584</pub-id></mixed-citation>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mäkikyrö</surname><given-names>T</given-names></name><name><surname>Karvonen</surname><given-names>JT</given-names></name><name><surname>Hakko</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort.</article-title>
<source/><italic>Public Health.</italic>
<year>1998</year>;<volume>112</volume>(<issue>4</issue>):<fpage>221</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="pmid">9724944</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cascella</surname><given-names>NG</given-names></name><name><surname>Schretlen</surname><given-names>DJ</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name></person-group>:
<article-title>Schizophrenia and epilepsy: is there a shared susceptibility?</article-title>
<source/><italic>Neurosci Res.</italic>
<year>2009</year>;<volume>63</volume>(<issue>4</issue>):<fpage>227</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neures.2009.01.002</pub-id>
<!--<pub-id pub-id-type="pmcid">2768382</pub-id>-->
<pub-id pub-id-type="pmid">19367784</pub-id></mixed-citation>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reilly</surname><given-names>C</given-names></name><name><surname>Atkinson</surname><given-names>P</given-names></name><name><surname>Das</surname><given-names>KB</given-names></name><etal></etal></person-group>:
<article-title>Neurobehavioral comorbidities in children with active epilepsy: a population-based study.</article-title>
<source/><italic>Pediatrics.</italic>
<year>2014</year>;<volume>133</volume>(<issue>6</issue>):<fpage>e1586</fpage>–<lpage>93</lpage>.
<pub-id pub-id-type="doi">10.1542/peds.2013-3787</pub-id>
<pub-id pub-id-type="pmid">24864167</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>AE</given-names></name><name><surname>Giust</surname><given-names>JM</given-names></name><name><surname>Kronenberger</surname><given-names>WG</given-names></name><etal></etal></person-group>:
<article-title>Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges.</article-title>
<source/><italic>Neuropsychiatr Dis Treat.</italic>
<year>2016</year>;<volume>12</volume>:<fpage>287</fpage>–<lpage>96</lpage>.
<pub-id pub-id-type="doi">10.2147/NDT.S81549</pub-id>
<!--<pub-id pub-id-type="pmcid">4755462</pub-id>-->
<pub-id pub-id-type="pmid">26929624</pub-id></mixed-citation>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buzsáki</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name></person-group>:
<article-title>Mechanisms of gamma oscillations.</article-title>
<source/><italic>Annu Rev Neurosci.</italic>
<year>2012</year>;<volume>35</volume>:<fpage>203</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-neuro-062111-150444</pub-id>
<!--<pub-id pub-id-type="pmcid">4049541</pub-id>-->
<pub-id pub-id-type="pmid">22443509</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Womelsdorf</surname><given-names>T</given-names></name><name><surname>Fries</surname><given-names>P</given-names></name><name><surname>Mitra</surname><given-names>PP</given-names></name><etal></etal></person-group>:
<article-title>Gamma-band synchronization in visual cortex predicts speed of change detection.</article-title>
<source/><italic>Nature.</italic>
<year>2006</year>;<volume>439</volume>(<issue>7077</issue>):<fpage>733</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1038/nature04258</pub-id>
<pub-id pub-id-type="pmid">16372022</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1030393">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tallon-Baudry</surname><given-names>C</given-names></name><name><surname>Bertrand</surname><given-names>O</given-names></name><name><surname>Peronnet</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Induced gamma-band activity during the delay of a visual short-term memory task in humans.</article-title>
<source/><italic>J Neurosci.</italic>
<year>1998</year>;<volume>18</volume>(<issue>11</issue>):<fpage>4244</fpage>–<lpage>54</lpage>.
<pub-id pub-id-type="pmid">9592102</pub-id></mixed-citation>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez-Burgos</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group>:
<article-title>GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.</article-title>
<source/><italic>Schizophr Bull.</italic>
<year>2008</year>;<volume>34</volume>(<issue>5</issue>):<fpage>944</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1093/schbul/sbn070</pub-id>
<!--<pub-id pub-id-type="pmcid">2518635</pub-id>-->
<pub-id pub-id-type="pmid">18586694</pub-id></mixed-citation>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cardin</surname><given-names>JA</given-names></name><name><surname>Carlén</surname><given-names>M</given-names></name><name><surname>Meletis</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Driving fast-spiking cells induces gamma rhythm and controls sensory responses.</article-title>
<source/><italic>Nature.</italic>
<year>2009</year>;<volume>459</volume>(<issue>7247</issue>):<fpage>663</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nature08002</pub-id>
<!--<pub-id pub-id-type="pmcid">3655711</pub-id>-->
<pub-id pub-id-type="pmid">19396156</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1160612">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sohal</surname><given-names>VS</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Yizhar</surname><given-names>O</given-names></name><etal></etal></person-group>:
<article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance.</article-title>
<source/><italic>Nature.</italic>
<year>2009</year>;<volume>459</volume>(<issue>7247</issue>):<fpage>698</fpage>–<lpage>702</lpage>.
<pub-id pub-id-type="doi">10.1038/nature07991</pub-id>
<!--<pub-id pub-id-type="pmcid">3969859</pub-id>-->
<pub-id pub-id-type="pmid">19396159</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1161515">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>YW</given-names></name><name><surname>O'Donnell</surname><given-names>BF</given-names></name><name><surname>Youn</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Gamma oscillation in schizophrenia.</article-title>
<source/><italic>Psychiatry Investig.</italic>
<year>2011</year>;<volume>8</volume>(<issue>4</issue>):<fpage>288</fpage>–<lpage>96</lpage>.
<pub-id pub-id-type="doi">10.4306/pi.2011.8.4.288</pub-id>
<!--<pub-id pub-id-type="pmcid">3246135</pub-id>-->
<pub-id pub-id-type="pmid">22216037</pub-id></mixed-citation>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>CM</given-names></name><name><surname>Stanford</surname><given-names>AD</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><etal></etal></person-group>:
<article-title>GABA level, gamma oscillation, and working memory performance in schizophrenia.</article-title>
<source/><italic>Neuroimage Clin.</italic>
<year>2014</year>;<volume>4</volume>:<fpage>531</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.nicl.2014.03.007</pub-id>
<!--<pub-id pub-id-type="pmcid">3989525</pub-id>-->
<pub-id pub-id-type="pmid">24749063</pub-id></mixed-citation>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farzan</surname><given-names>F</given-names></name><name><surname>Barr</surname><given-names>MS</given-names></name><name><surname>Levinson</surname><given-names>AJ</given-names></name><etal></etal></person-group>:
<article-title>Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.</article-title>
<source/><italic>Brain.</italic>
<year>2010</year>;<volume>133</volume>(<issue>Pt 5</issue>):<fpage>1505</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1093/brain/awq046</pub-id>
<pub-id pub-id-type="pmid">20350936</pub-id></mixed-citation>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Haig</surname><given-names>AR</given-names></name><etal></etal></person-group>:
<article-title>Symptom profile and “gamma” processing in schizophrenia.</article-title>
<source/><italic>Cogn Neuropsychiatry.</italic>
<year>2001</year>;<volume>6</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>19</lpage>.
<pub-id pub-id-type="doi">10.1080/13546800042000016</pub-id>
</mixed-citation>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baldeweg</surname><given-names>T</given-names></name><name><surname>Spence</surname><given-names>S</given-names></name><name><surname>Hirsch</surname><given-names>SR</given-names></name><etal></etal></person-group>:
<article-title>Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations.</article-title>
<source/><italic>Lancet.</italic>
<year>1998</year>;<volume>352</volume>(<issue>9128</issue>):<fpage>620</fpage>–<lpage>1</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(05)79575-1</pub-id>
<pub-id pub-id-type="pmid">9746027</pub-id></mixed-citation>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landau</surname><given-names>ID</given-names></name><name><surname>Egger</surname><given-names>R</given-names></name><name><surname>Dercksen</surname><given-names>VJ</given-names></name><etal></etal></person-group>:
<article-title>The Impact of Structural Heterogeneity on Excitation-Inhibition Balance in Cortical Networks.</article-title>
<source/><italic>Neuron.</italic>
<year>2016</year>;<volume>92</volume>(<issue>5</issue>):<fpage>1106</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.027</pub-id>
<!--<pub-id pub-id-type="pmcid">5158120</pub-id>-->
<pub-id pub-id-type="pmid">27866797</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726993813">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vierling-Claassen</surname><given-names>D</given-names></name><name><surname>Siekmeier</surname><given-names>P</given-names></name><name><surname>Stufflebeam</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2008</year>;<volume>99</volume>(<issue>5</issue>):<fpage>2656</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.00870.2007</pub-id>
<!--<pub-id pub-id-type="pmcid">2679675</pub-id>-->
<pub-id pub-id-type="pmid">18287555</pub-id></mixed-citation>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uhlhaas</surname><given-names>PJ</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name></person-group>:
<article-title>Abnormal neural oscillations and synchrony in schizophrenia.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2010</year>;<volume>11</volume>(<issue>2</issue>):<fpage>100</fpage>–<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn2774</pub-id>
<pub-id pub-id-type="pmid">20087360</pub-id></mixed-citation>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rojas</surname><given-names>DC</given-names></name><name><surname>Maharajh</surname><given-names>K</given-names></name><name><surname>Teale</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism.</article-title>
<source/><italic>BMC Psychiatry.</italic>
<year>2008</year>;<volume>8</volume>:<fpage>66</fpage>.
<pub-id pub-id-type="doi">10.1186/1471-244X-8-66</pub-id>
<!--<pub-id pub-id-type="pmcid">2518921</pub-id>-->
<pub-id pub-id-type="pmid">18673566</pub-id></mixed-citation>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rojas</surname><given-names>DC</given-names></name><name><surname>Wilson</surname><given-names>LB</given-names></name></person-group>:
<article-title>γ-band abnormalities as markers of autism spectrum disorders.</article-title>
<source/><italic>Biomark Med.</italic>
<year>2014</year>;<volume>8</volume>(<issue>3</issue>):<fpage>353</fpage>–<lpage>68</lpage>.
<pub-id pub-id-type="doi">10.2217/bmm.14.15</pub-id>
<!--<pub-id pub-id-type="pmcid">4105225</pub-id>-->
<pub-id pub-id-type="pmid">24712425</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lenz</surname><given-names>D</given-names></name><name><surname>Krauel</surname><given-names>K</given-names></name><name><surname>Schadow</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Enhanced gamma-band activity in ADHD patients lacks correlation with memory performance found in healthy children.</article-title>
<source/><italic>Brain Res.</italic>
<year>2008</year>;<volume>1235</volume>:<fpage>117</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1016/j.brainres.2008.06.023</pub-id>
<pub-id pub-id-type="pmid">18598680</pub-id></mixed-citation>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamida</surname><given-names>A</given-names></name><name><surname>Shimabayashi</surname><given-names>K</given-names></name><name><surname>Oguri</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>EEG Power Spectrum Analysis in Children with ADHD.</article-title>
<source/><italic>Yonago Acta Med.</italic>
<year>2016</year>;<volume>59</volume>(<issue>2</issue>):<fpage>169</fpage>–<lpage>73</lpage>.
<!--<pub-id pub-id-type="pmcid">4973024</pub-id>-->
<pub-id pub-id-type="pmid">27493489</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726617408">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karch</surname><given-names>S</given-names></name><name><surname>Segmiller</surname><given-names>F</given-names></name><name><surname>Hantschk</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Increased γ oscillations during voluntary selection processes in adult patients with attention deficit/hyperactivity disorder.</article-title>
<source/><italic>J Psychiatr Res.</italic>
<year>2012</year>;<volume>46</volume>(<issue>11</issue>):<fpage>1515</fpage>–<lpage>23</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2012.07.017</pub-id>
<pub-id pub-id-type="pmid">22921861</pub-id></mixed-citation>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yordanova</surname><given-names>J</given-names></name><name><surname>Banaschewski</surname><given-names>T</given-names></name><name><surname>Kolev</surname><given-names>V</given-names></name><etal></etal></person-group>:
<article-title>Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder--evidence from event-related gamma oscillations.</article-title>
<source/><italic>Clin Neurophysiol.</italic>
<year>2001</year>;<volume>112</volume>(<issue>6</issue>):<fpage>1096</fpage>–<lpage>108</lpage>.
<pub-id pub-id-type="doi">10.1016/S1388-2457(01)00524-7</pub-id>
<pub-id pub-id-type="pmid">11377270</pub-id></mixed-citation>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Özerdem</surname><given-names>A</given-names></name><name><surname>Güntekin</surname><given-names>B</given-names></name><name><surname>Atagün</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Reduced long distance gamma (28–48 Hz) coherence in euthymic patients with bipolar disorder.</article-title>
<source/><italic>J Affect Disord.</italic>
<year>2011</year>;<volume>132</volume>(<issue>3</issue>):<fpage>325</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jad.2011.02.028</pub-id>
<!--<pub-id pub-id-type="pmcid">4530485</pub-id>-->
<pub-id pub-id-type="pmid">21459454</pub-id></mixed-citation>
</ref>
<ref id="ref-64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stroganova</surname><given-names>TA</given-names></name><name><surname>Butorina</surname><given-names>AV</given-names></name><name><surname>Sysoeva</surname><given-names>OV</given-names></name><etal></etal></person-group>:
<article-title>Altered modulation of gamma oscillation frequency by speed of visual motion in children with autism spectrum disorders.</article-title>
<source/><italic>J Neurodev Disord.</italic>
<year>2015</year>;<volume>7</volume>(<issue>1</issue>):<fpage>21</fpage>.
<pub-id pub-id-type="doi">10.1186/s11689-015-9121-x</pub-id>
<!--<pub-id pub-id-type="pmcid">4530485</pub-id>-->
<pub-id pub-id-type="pmid">26261460</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725710009">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Petilla Interneuron Nomenclature Group, </collab><name><surname>Ascoli</surname><given-names>GA</given-names></name><name><surname>Alonso-Nanclares</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2008</year>;<volume>9</volume>(<issue>7</issue>):<fpage>557</fpage>–<lpage>68</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn2402</pub-id>
<!--<pub-id pub-id-type="pmcid">2868386</pub-id>-->
<pub-id pub-id-type="pmid">18568015</pub-id></mixed-citation>
</ref>
<ref id="ref-66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DeFelipe</surname><given-names>J</given-names></name><name><surname>López-Cruz</surname><given-names>PL</given-names></name><name><surname>Benavides-Piccione</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>New insights into the classification and nomenclature of cortical GABAergic interneurons.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2013</year>;<volume>14</volume>(<issue>3</issue>):<fpage>202</fpage>–<lpage>16</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn3444</pub-id>
<!--<pub-id pub-id-type="pmcid">3619199</pub-id>-->
<pub-id pub-id-type="pmid">23385869</pub-id></mixed-citation>
</ref>
<ref id="ref-67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kepecs</surname><given-names>A</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name></person-group>:
<article-title>Interneuron cell types are fit to function.</article-title>
<source/><italic>Nature.</italic>
<year>2014</year>;<volume>505</volume>(<issue>7483</issue>):<fpage>318</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12983</pub-id>
<!--<pub-id pub-id-type="pmcid">4349583</pub-id>-->
<pub-id pub-id-type="pmid">24429630</pub-id></mixed-citation>
</ref>
<ref id="ref-68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rudy</surname><given-names>B</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons.</article-title>
<source/><italic>Dev Neurobiol.</italic>
<year>2011</year>;<volume>71</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1002/dneu.20853</pub-id>
<!--<pub-id pub-id-type="pmcid">3556905</pub-id>-->
<pub-id pub-id-type="pmid">21154909</pub-id></mixed-citation>
</ref>
<ref id="ref-69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pi</surname><given-names>H</given-names></name><name><surname>Hangya</surname><given-names>B</given-names></name><name><surname>Kvitsiani</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Cortical interneurons that specialize in disinhibitory control.</article-title>
<source/><italic>Nature.</italic>
<year>2013</year>;<volume>503</volume>(<issue>7477</issue>):<fpage>521</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12676</pub-id>
<!--<pub-id pub-id-type="pmcid">4017628</pub-id>-->
<pub-id pub-id-type="pmid">24097352</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718133661">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kruglikov</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><etal></etal></person-group>:
<article-title>A disinhibitory circuit mediates motor integration in the somatosensory cortex.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>11</issue>):<fpage>1662</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3544</pub-id>
<!--<pub-id pub-id-type="pmcid">4100076</pub-id>-->
<pub-id pub-id-type="pmid">24097044</pub-id></mixed-citation>
</ref>
<ref id="ref-71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Tucciarone</surname><given-names>JM</given-names></name><name><surname>Espinosa</surname><given-names>JS</given-names></name><etal></etal></person-group>:
<article-title>A cortical circuit for gain control by behavioral state.</article-title>
<source/><italic>Cell.</italic>
<year>2014</year>;<volume>156</volume>(<issue>6</issue>):<fpage>1139</fpage>–<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2014.01.050</pub-id>
<!--<pub-id pub-id-type="pmcid">4041382</pub-id>-->
<pub-id pub-id-type="pmid">24630718</pub-id></mixed-citation>
</ref>
<ref id="ref-72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>CK</given-names></name><name><surname>Xue</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>8</issue>):<fpage>1068</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3446</pub-id>
<!--<pub-id pub-id-type="pmcid">3729586</pub-id>-->
<pub-id pub-id-type="pmid">23817549</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718024999">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J</given-names></name><name><surname>Ayzenshtat</surname><given-names>I</given-names></name><name><surname>Karnani</surname><given-names>MM</given-names></name><etal></etal></person-group>:
<article-title>VIP+ interneurons control neocortical activity across brain states.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2016</year>;<volume>115</volume>(<issue>6</issue>):<fpage>3008</fpage>–<lpage>17</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.01124.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">4946593</pub-id>-->
<pub-id pub-id-type="pmid">26961109</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726210281">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Batista-Brito</surname><given-names>R</given-names></name><name><surname>Vinck</surname><given-names>M</given-names></name><name><surname>Ferguson</surname><given-names>KA</given-names></name><etal></etal></person-group>:
<article-title>Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits.</article-title>
<source/><italic>Neuron.</italic>
<year>2017</year>;<volume>95</volume>(<issue>4</issue>):<fpage>884</fpage>–<lpage>895.e9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.034</pub-id>
<!--<pub-id pub-id-type="pmcid">5595250</pub-id>-->
<pub-id pub-id-type="pmid">28817803</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/728769154">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Junco-Clemente</surname><given-names>P</given-names></name><name><surname>Ikrar</surname><given-names>T</given-names></name><name><surname>Tring</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>An inhibitory pull-push circuit in frontal cortex.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2017</year>;<volume>20</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>92</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.4483</pub-id>
<pub-id pub-id-type="pmid">28114295</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727231168">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vacic</surname><given-names>V</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Malhotra</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia.</article-title>
<source/><italic>Nature.</italic>
<year>2011</year>;<volume>471</volume>(<issue>7339</issue>):<fpage>499</fpage>–<lpage>503</lpage>.
<pub-id pub-id-type="doi">10.1038/nature09884</pub-id>
<!--<pub-id pub-id-type="pmcid">3351382</pub-id>-->
<pub-id pub-id-type="pmid">21346763</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/10508956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CQ</given-names></name><name><surname>Lur</surname><given-names>G</given-names></name><name><surname>Morse</surname><given-names>TM</given-names></name><etal></etal></person-group>:
<article-title>Compartmentalization of GABAergic inhibition by dendritic spines.</article-title>
<source/><italic>Science.</italic>
<year>2013</year>;<volume>340</volume>(<issue>6133</issue>):<fpage>759</fpage>–<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1234274</pub-id>
<!--<pub-id pub-id-type="pmcid">3752161</pub-id>-->
<pub-id pub-id-type="pmid">23661763</pub-id></mixed-citation>
</ref>
<ref id="ref-78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gentet</surname><given-names>LJ</given-names></name><name><surname>Kremer</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2012</year>;<volume>15</volume>(<issue>4</issue>):<fpage>607</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3051</pub-id>
<pub-id pub-id-type="pmid">22366760</pub-id></mixed-citation>
</ref>
<ref id="ref-79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scheyltjens</surname><given-names>I</given-names></name><name><surname>Arckens</surname><given-names>L</given-names></name></person-group>:
<article-title>The Current Status of Somatostatin-Interneurons in Inhibitory Control of Brain Function and Plasticity.</article-title>
<source/><italic>Neural Plast.</italic>
<year>2016</year>;<volume>2016</volume>: 8723623.
<pub-id pub-id-type="doi">10.1155/2016/8723623</pub-id>
<!--<pub-id pub-id-type="pmcid">4923604</pub-id>-->
<pub-id pub-id-type="pmid">27403348</pub-id></mixed-citation>
</ref>
<ref id="ref-80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cichon</surname><given-names>J</given-names></name><name><surname>Gan</surname><given-names>W</given-names></name></person-group>:
<article-title>Branch-specific dendritic Ca
<sup>2+</sup> spikes cause persistent synaptic plasticity.</article-title>
<source/><italic>Nature.</italic>
<year>2015</year>;<volume>520</volume>(<issue>7546</issue>):<fpage>180</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1038/nature14251</pub-id>
<!--<pub-id pub-id-type="pmcid">4476301</pub-id>-->
<pub-id pub-id-type="pmid">25822789</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725408915">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>T</given-names></name><name><surname>Jefferson</surname><given-names>SJ</given-names></name><name><surname>Hooper</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.</article-title>
<source/><italic>Mol Psychiatry.</italic>
<year>2017</year>;<volume>22</volume>(<issue>6</issue>):<fpage>920</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2016.188</pub-id>
<!--<pub-id pub-id-type="pmcid">5422144</pub-id>-->
<pub-id pub-id-type="pmid">27821870</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726943368">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Sibille</surname><given-names>E</given-names></name></person-group>:
<article-title>Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?</article-title>
<source/><italic>Front Pharmacol.</italic>
<year>2013</year>;<volume>4</volume>:<fpage>110</fpage>.
<pub-id pub-id-type="doi">10.3389/fphar.2013.00110</pub-id>
<!--<pub-id pub-id-type="pmcid">3766825</pub-id>-->
<pub-id pub-id-type="pmid">24058344</pub-id></mixed-citation>
</ref>
<ref id="ref-83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Veit</surname><given-names>J</given-names></name><name><surname>Hakim</surname><given-names>R</given-names></name><name><surname>Jadi</surname><given-names>MP</given-names></name><etal></etal></person-group>:
<article-title>Cortical gamma band synchronization through somatostatin interneurons.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2017</year>;<volume>20</volume>(<issue>7</issue>):<fpage>951</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.4562</pub-id>
<!--<pub-id pub-id-type="pmcid">5511041</pub-id>-->
<pub-id pub-id-type="pmid">28481348</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727591070">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bezaire</surname><given-names>MJ</given-names></name><name><surname>Soltesz</surname><given-names>I</given-names></name></person-group>:
<article-title>Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity.</article-title>
<source/><italic>Hippocampus.</italic>
<year>2013</year>;<volume>23</volume>(<issue>9</issue>):<fpage>751</fpage>–<lpage>85</lpage>.
<pub-id pub-id-type="doi">10.1002/hipo.22141</pub-id>
<!--<pub-id pub-id-type="pmcid">3775914</pub-id>-->
<pub-id pub-id-type="pmid">23674373</pub-id></mixed-citation>
</ref>
<ref id="ref-85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Gan</surname><given-names>J</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name></person-group>:
<article-title>Interneurons. Fast-spiking, parvalbumin
<sup>+</sup> GABAergic interneurons: from cellular design to microcircuit function.</article-title>
<source/><italic>Science.</italic>
<year>2014</year>;<volume>345</volume>(<issue>6196</issue>):<fpage>1255263</fpage>.
<pub-id pub-id-type="doi">10.1126/science.1255263</pub-id>
<pub-id pub-id-type="pmid">25082707</pub-id></mixed-citation>
</ref>
<ref id="ref-86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nelson</surname><given-names>SB</given-names></name><name><surname>Valakh</surname><given-names>V</given-names></name></person-group>:
<article-title>Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.</article-title>
<source/><italic>Neuron.</italic>
<year>2015</year>;<volume>87</volume>(<issue>4</issue>):<fpage>684</fpage>–<lpage>98</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id>
<!--<pub-id pub-id-type="pmcid">4567857</pub-id>-->
<pub-id pub-id-type="pmid">26291155</pub-id></mixed-citation>
</ref>
<ref id="ref-87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klausberger</surname><given-names>T</given-names></name><name><surname>Somogyi</surname><given-names>P</given-names></name></person-group>:
<article-title>Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.</article-title>
<source/><italic>Science.</italic>
<year>2008</year>;<volume>321</volume>(<issue>5885</issue>):<fpage>53</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1149381</pub-id>
<!--<pub-id pub-id-type="pmcid">4487503</pub-id>-->
<pub-id pub-id-type="pmid">18599766</pub-id></mixed-citation>
</ref>
<ref id="ref-88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tricoire</surname><given-names>L</given-names></name><name><surname>Pelkey</surname><given-names>KA</given-names></name><name><surname>Erkkila</surname><given-names>BE</given-names></name><etal></etal></person-group>:
<article-title>A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2011</year>;<volume>31</volume>(<issue>30</issue>):<fpage>10948</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0323-11.2011</pub-id>
<!--<pub-id pub-id-type="pmcid">3163481</pub-id>-->
<pub-id pub-id-type="pmid">21795545</pub-id></mixed-citation>
</ref>
<ref id="ref-89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pouille</surname><given-names>F</given-names></name><name><surname>Scanziani</surname><given-names>M</given-names></name></person-group>:
<article-title>Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition.</article-title>
<source/><italic>Science.</italic>
<year>2001</year>;<volume>293</volume>(<issue>5532</issue>):<fpage>1159</fpage>–<lpage>63</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1060342</pub-id>
<pub-id pub-id-type="pmid">11498596</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1001136">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name></person-group>:
<article-title>A supercritical density of Na
<sup>+</sup> channels ensures fast signaling in GABAergic interneuron axons.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2014</year>;<volume>17</volume>(<issue>5</issue>):<fpage>686</fpage>–<lpage>93</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3678</pub-id>
<!--<pub-id pub-id-type="pmcid">4286295</pub-id>-->
<pub-id pub-id-type="pmid">24657965</pub-id></mixed-citation>
</ref>
<ref id="ref-91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogiwara</surname><given-names>I</given-names></name><name><surname>Miyamoto</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Na
<sub>v</sub>1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an
<italic>Scn1a</italic> gene mutation.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2007</year>;<volume>27</volume>(<issue>22</issue>):<fpage>5903</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5270-06.2007</pub-id>
<pub-id pub-id-type="pmid">17537961</pub-id></mixed-citation>
</ref>
<ref id="ref-92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaitsev</surname><given-names>AV</given-names></name><name><surname>Povysheva</surname><given-names>NV</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name><etal></etal></person-group>:
<article-title>P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2007</year>;<volume>97</volume>(<issue>5</issue>):<fpage>3567</fpage>–<lpage>73</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.01293.2006</pub-id>
<pub-id pub-id-type="pmid">17329622</pub-id></mixed-citation>
</ref>
<ref id="ref-93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bucurenciu</surname><given-names>I</given-names></name><name><surname>Kulik</surname><given-names>A</given-names></name><name><surname>Schwaller</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Nanodomain coupling between Ca
<sup>2+</sup> channels and Ca
<sup>2+</sup> sensors promotes fast and efficient transmitter release at a cortical GABAergic synapse.</article-title>
<source/><italic>Neuron.</italic>
<year>2008</year>;<volume>57</volume>(<issue>4</issue>):<fpage>536</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.026</pub-id>
<pub-id pub-id-type="pmid">18304483</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1157074">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baude</surname><given-names>A</given-names></name><name><surname>Bleasdale</surname><given-names>C</given-names></name><name><surname>Dalezios</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Immunoreactivity for the GABAA receptor alpha1 subunit, somatostatin and Connexin36 distinguishes axoaxonic, basket, and bistratified interneurons of the rat hippocampus.</article-title>
<source/><italic>Cereb Cortex.</italic>
<year>2007</year>;<volume>17</volume>(<issue>9</issue>):<fpage>2094</fpage>–<lpage>107</lpage>.
<pub-id pub-id-type="doi">10.1093/cercor/bhl117</pub-id>
<pub-id pub-id-type="pmid">17122364</pub-id></mixed-citation>
</ref>
<ref id="ref-95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palay</surname><given-names>SL</given-names></name><name><surname>Sotelo</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>The axon hillock and the initial segment.</article-title>
<source/><italic>J Cell Biol.</italic>
<year>1968</year>;<volume>38</volume>(<issue>1</issue>):<fpage>193</fpage>–<lpage>201</lpage>.
<pub-id pub-id-type="doi">10.1083/jcb.38.1.193</pub-id>
<!--<pub-id pub-id-type="pmcid">2107452</pub-id>-->
<pub-id pub-id-type="pmid">5691973</pub-id></mixed-citation>
</ref>
<ref id="ref-96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Somogyi</surname><given-names>P</given-names></name></person-group>:
<article-title>A specific 'axo-axonal' interneuron in the visual cortex of the rat.</article-title>
<source/><italic>Brain Res.</italic>
<year>1977</year>;<volume>136</volume>(<issue>2</issue>):<fpage>345</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1016/0006-8993(77)90808-3</pub-id>
<pub-id pub-id-type="pmid">922488</pub-id></mixed-citation>
</ref>
<ref id="ref-97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Inan</surname><given-names>M</given-names></name><name><surname>Blázquez-Llorca</surname><given-names>L</given-names></name><name><surname>Merchán-Pérez</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Dense and overlapping innervation of pyramidal neurons by chandelier cells.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2013</year>;<volume>33</volume>(<issue>5</issue>):<fpage>1907</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4049-12.2013</pub-id>
<!--<pub-id pub-id-type="pmcid">3711719</pub-id>-->
<pub-id pub-id-type="pmid">23365230</pub-id></mixed-citation>
</ref>
<ref id="ref-98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Wyskiel</surname><given-names>DR</given-names></name></person-group>:
<article-title>Chandelier Cells in Functional and Dysfunctional Neural Circuits.</article-title>
<source/><italic>Front Neural Circuits.</italic>
<year>2016</year>;<volume>10</volume>:<fpage>33</fpage>.
<pub-id pub-id-type="doi">10.3389/fncir.2016.00033</pub-id>
<!--<pub-id pub-id-type="pmcid">4854894</pub-id>-->
<pub-id pub-id-type="pmid">27199673</pub-id></mixed-citation>
</ref>
<ref id="ref-99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Inda</surname><given-names>MC</given-names></name><name><surname>Defelipe</surname><given-names>J</given-names></name><name><surname>Muñoz</surname><given-names>A</given-names></name></person-group>:
<article-title>The distribution of chandelier cell axon terminals that express the GABA plasma membrane transporter GAT-1 in the human neocortex.</article-title>
<source/><italic>Cereb Cortex.</italic>
<year>2007</year>;<volume>17</volume>(<issue>9</issue>):<fpage>2060</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1093/cercor/bhl114</pub-id>
<pub-id pub-id-type="pmid">17099065</pub-id></mixed-citation>
</ref>
<ref id="ref-100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cruz</surname><given-names>DA</given-names></name><name><surname>Eggan</surname><given-names>SM</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group>:
<article-title>Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex.</article-title>
<source/><italic>J Comp Neurol.</italic>
<year>2003</year>;<volume>465</volume>(<issue>3</issue>):<fpage>385</fpage>–<lpage>400</lpage>.
<pub-id pub-id-type="doi">10.1002/cne.10833</pub-id>
<pub-id pub-id-type="pmid">12966563</pub-id></mixed-citation>
</ref>
<ref id="ref-101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z</given-names></name><name><surname>Sieghart</surname><given-names>W</given-names></name><name><surname>Benke</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>1996</year>;<volume>93</volume>(<issue>21</issue>):<fpage>11939</fpage>–<lpage>44</lpage>.
<!--<pub-id pub-id-type="pmcid">38162</pub-id>-->
<pub-id pub-id-type="pmid">8876241</pub-id></mixed-citation>
</ref>
<ref id="ref-102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nyíri</surname><given-names>G</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name><name><surname>Somogyi</surname><given-names>P</given-names></name></person-group>:
<article-title>Input-dependent synaptic targeting of alpha
<sub>2</sub>-subunit-containing GABA
<sub>A</sub> receptors in synapses of hippocampal pyramidal cells of the rat.</article-title>
<source/><italic>Eur J Neurosci.</italic>
<year>2001</year>;<volume>13</volume>(<issue>3</issue>):<fpage>428</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1046/j.1460-9568.2001.01407.x</pub-id>
<pub-id pub-id-type="pmid">11168550</pub-id></mixed-citation>
</ref>
<ref id="ref-103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CS</given-names></name><name><surname>Jensen</surname><given-names>K</given-names></name><name><surname>Sokolova</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2002</year>;<volume>22</volume>(<issue>23</issue>):<fpage>10251</fpage>–<lpage>66</lpage>.
<pub-id pub-id-type="pmid">12451126</pub-id></mixed-citation>
</ref>
<ref id="ref-104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Stornetta</surname><given-names>RL</given-names></name><name><surname>Zhu</surname><given-names>JJ</given-names></name></person-group>:
<article-title>Chandelier cells control excessive cortical excitation: characteristics of whisker-evoked synaptic responses of layer 2/3 nonpyramidal and pyramidal neurons.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2004</year>;<volume>24</volume>(<issue>22</issue>):<fpage>5101</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0544-04.2004</pub-id>
<pub-id pub-id-type="pmid">15175379</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1019463">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ribak</surname><given-names>CE</given-names></name></person-group>:
<article-title>Axon terminals of GABAergic chandelier cells are lost at epileptic foci.</article-title>
<source/><italic>Brain Res.</italic>
<year>1985</year>;<volume>326</volume>(<issue>2</issue>):<fpage>251</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1016/0006-8993(85)90034-4</pub-id>
<pub-id pub-id-type="pmid">2982461</pub-id></mixed-citation>
</ref>
<ref id="ref-106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Defelipe</surname><given-names>J</given-names></name></person-group>:
<article-title>Chandelier cells and epilepsy.</article-title>
<source/><italic>Brain.</italic>
<year>1999</year>;<volume>122</volume>(<issue>Pt 10</issue>):<fpage>1807</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1093/brain/122.10.1807</pub-id>
<pub-id pub-id-type="pmid">10506085</pub-id></mixed-citation>
</ref>
<ref id="ref-107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dinocourt</surname><given-names>C</given-names></name><name><surname>Petanjek</surname><given-names>Z</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name><etal></etal></person-group>:
<article-title>Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures.</article-title>
<source/><italic>J Comp Neurol.</italic>
<year>2003</year>;<volume>459</volume>(<issue>4</issue>):<fpage>407</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1002/cne.10622</pub-id>
<pub-id pub-id-type="pmid">12687707</pub-id></mixed-citation>
</ref>
<ref id="ref-108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodruff</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name><etal></etal></person-group>:
<article-title>Depolarizing effect of neocortical chandelier neurons.</article-title>
<source/><italic>Front Neural Circuits.</italic>
<year>2009</year>;<volume>3</volume>:<fpage>15</fpage>.
<pub-id pub-id-type="doi">10.3389/neuro.04.015.2009</pub-id>
<!--<pub-id pub-id-type="pmcid">2769545</pub-id>-->
<pub-id pub-id-type="pmid">19876404</pub-id></mixed-citation>
</ref>
<ref id="ref-109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szabadics</surname><given-names>J</given-names></name><name><surname>Varga</surname><given-names>C</given-names></name><name><surname>Molnár</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits.</article-title>
<source/><italic>Science.</italic>
<year>2006</year>;<volume>311</volume>(<issue>5758</issue>):<fpage>233</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1121325</pub-id>
<pub-id pub-id-type="pmid">16410524</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1030409">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hooks</surname><given-names>BM</given-names></name><name><surname>Sun</surname><given-names>QQ</given-names></name></person-group>:
<article-title>Thorough GABAergic innervation of the entire axon initial segment revealed by an optogenetic 'laserspritzer'.</article-title>
<source/><italic>J Physiol.</italic>
<year>2014</year>;<volume>592</volume>(<issue>19</issue>):<fpage>4257</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1113/jphysiol.2014.275719</pub-id>
<!--<pub-id pub-id-type="pmcid">4215776</pub-id>-->
<pub-id pub-id-type="pmid">25085892</pub-id></mixed-citation>
</ref>
<ref id="ref-111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodruff</surname><given-names>AR</given-names></name><name><surname>McGarry</surname><given-names>LM</given-names></name><name><surname>Vogels</surname><given-names>TP</given-names></name><etal></etal></person-group>:
<article-title>State-dependent function of neocortical chandelier cells.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2011</year>;<volume>31</volume>(<issue>49</issue>):<fpage>17872</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3894-11.2011.</pub-id>
<!--<pub-id pub-id-type="pmcid">4071969</pub-id>-->
<pub-id pub-id-type="pmid">22159102</pub-id></mixed-citation>
</ref>
<ref id="ref-112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Massi</surname><given-names>L</given-names></name><name><surname>Lagler</surname><given-names>M</given-names></name><name><surname>Hartwich</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Temporal dynamics of parvalbumin-expressing axo-axonic and basket cells in the rat medial prefrontal cortex
<italic>in vivo</italic>.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2012</year>;<volume>32</volume>(<issue>46</issue>):<fpage>16496</fpage>–<lpage>502</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3475-12.2012</pub-id>
<!--<pub-id pub-id-type="pmcid">4487822</pub-id>-->
<pub-id pub-id-type="pmid">23152631</pub-id></mixed-citation>
</ref>
<ref id="ref-113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viney</surname><given-names>TJ</given-names></name><name><surname>Lasztoczi</surname><given-names>B</given-names></name><name><surname>Katona</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells
<italic>in vivo</italic>.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>12</issue>):<fpage>1802</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3550</pub-id>
<!--<pub-id pub-id-type="pmcid">4471148</pub-id>-->
<pub-id pub-id-type="pmid">24141313</pub-id></mixed-citation>
</ref>
<ref id="ref-114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rocco</surname><given-names>BR</given-names></name><name><surname>DeDionisio</surname><given-names>AM</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name><etal></etal></person-group>:
<article-title>Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia.</article-title>
<source/><italic>Biol Psychiatry.</italic>
<year>2017</year>;<volume>82</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.09.018</pub-id>
<!--<pub-id pub-id-type="pmcid">5374057</pub-id>-->
<pub-id pub-id-type="pmid">27884423</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727055904">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-115">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pierri</surname><given-names>JN</given-names></name><name><surname>Chaudry</surname><given-names>AS</given-names></name><name><surname>Woo</surname><given-names>TU</given-names></name><etal></etal></person-group>:
<article-title>Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.</article-title>
<source/><italic>Am J Psychiatry.</italic>
<year>1999</year>;<volume>156</volume>(<issue>11</issue>):<fpage>1709</fpage>–<lpage>19</lpage>.
<pub-id pub-id-type="pmid">10553733</pub-id></mixed-citation>
</ref>
<ref id="ref-116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schleimer</surname><given-names>SB</given-names></name><name><surname>Hinton</surname><given-names>T</given-names></name><name><surname>Dixon</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia.</article-title>
<source/><italic>Neuropsychobiology.</italic>
<year>2004</year>;<volume>50</volume>(<issue>3</issue>):<fpage>226</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1159/000079975</pub-id>
<pub-id pub-id-type="pmid">15365220</pub-id></mixed-citation>
</ref>
<ref id="ref-117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volk</surname><given-names>D</given-names></name><name><surname>Austin</surname><given-names>M</given-names></name><name><surname>Pierri</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.</article-title>
<source/><italic>Am J Psychiatry.</italic>
<year>2001</year>;<volume>158</volume>(<issue>2</issue>):<fpage>256</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1176/appi.ajp.158.2.256</pub-id>
<pub-id pub-id-type="pmid">11156808</pub-id></mixed-citation>
</ref>
<ref id="ref-118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volk</surname><given-names>DW</given-names></name><name><surname>Pierri</surname><given-names>JN</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name><etal></etal></person-group>:
<article-title>Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.</article-title>
<source/><italic>Cereb Cortex.</italic>
<year>2002</year>;<volume>12</volume>(<issue>10</issue>):<fpage>1063</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="pmid">12217970</pub-id></mixed-citation>
</ref>
<ref id="ref-119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard</surname><given-names>A</given-names></name><name><surname>Tamas</surname><given-names>G</given-names></name><name><surname>Soltesz</surname><given-names>I</given-names></name></person-group>:
<article-title>Lighting the chandelier: new vistas for axo-axonic cells.</article-title>
<source/><italic>Trends Neurosci.</italic>
<year>2005</year>;<volume>28</volume>(<issue>6</issue>):<fpage>310</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/j.tins.2005.04.004</pub-id>
<pub-id pub-id-type="pmid">15927687</pub-id></mixed-citation>
</ref>
<ref id="ref-120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Del Pino</surname><given-names>I</given-names></name><name><surname>García-Frigola</surname><given-names>C</given-names></name><name><surname>Dehorter</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Erbb4</italic> deletion from fast-spiking interneurons causes schizophrenia-like phenotypes.</article-title>
<source/><italic>Neuron.</italic>
<year>2013</year>;<volume>79</volume>(<issue>6</issue>):<fpage>1152</fpage>–<lpage>68</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.010</pub-id>
<pub-id pub-id-type="pmid">24050403</pub-id></mixed-citation>
</ref>
<ref id="ref-121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ting</surname><given-names>AK</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2011</year>;<volume>31</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2538-10.2011</pub-id>
<!--<pub-id pub-id-type="pmcid">3078582</pub-id>-->
<pub-id pub-id-type="pmid">21209185</pub-id></mixed-citation>
</ref>
<ref id="ref-122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibson</surname><given-names>JR</given-names></name><name><surname>Bartley</surname><given-names>AF</given-names></name><name><surname>Hays</surname><given-names>SA</given-names></name><etal></etal></person-group>:
<article-title>Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2008</year>;<volume>100</volume>(<issue>5</issue>):<fpage>2615</fpage>–<lpage>26</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.90752.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2585391</pub-id>-->
<pub-id pub-id-type="pmid">18784272</pub-id></mixed-citation>
</ref>
<ref id="ref-123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Faust</surname><given-names>T</given-names></name><name><surname>Ishizuka</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex.</article-title>
<source/><italic>Nat Commun.</italic>
<year>2015</year>;<volume>6</volume>: 10118.
<pub-id pub-id-type="doi">10.1038/ncomms10118</pub-id>
<!--<pub-id pub-id-type="pmcid">4682104</pub-id>-->
<pub-id pub-id-type="pmid">26656849</pub-id></mixed-citation>
</ref>
<ref id="ref-124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Polepalli</surname><given-names>JS</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Goswami</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Modulation of excitation on parvalbumin interneurons by neuroligin-3 regulates the hippocampal network.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2017</year>;<volume>20</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>29</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.4471</pub-id>
<!--<pub-id pub-id-type="pmcid">5272845</pub-id>-->
<pub-id pub-id-type="pmid">28067903</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727188044">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Cheng</surname><given-names>TL</given-names></name><etal></etal></person-group>:
<article-title>Conditional deletion of
<italic>Mecp2</italic> in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity.</article-title>
<source/><italic>Nat Commun.</italic>
<year>2014</year>;<volume>5</volume>(<issue>1</issue>): 5036.
<pub-id pub-id-type="doi">10.1038/ncomms6036</pub-id>
<pub-id pub-id-type="pmid">25297674</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/720585084">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Papaleo</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Role of dysbindin in dopamine receptor trafficking and cortical GABA function.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2009</year>;<volume>106</volume>(<issue>46</issue>):<fpage>19593</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0904289106</pub-id>
<!--<pub-id pub-id-type="pmcid">2780743</pub-id>-->
<pub-id pub-id-type="pmid">19887632</pub-id></mixed-citation>
</ref>
<ref id="ref-127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>FH</given-names></name><name><surname>Mantegazza</surname><given-names>M</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><etal></etal></person-group>:
<article-title>Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2006</year>;<volume>9</volume>(<issue>9</issue>):<fpage>1142</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nn1754</pub-id>
<pub-id pub-id-type="pmid">16921370</pub-id></mixed-citation>
</ref>
<ref id="ref-128">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fazzari</surname><given-names>P</given-names></name><name><surname>Paternain</surname><given-names>AV</given-names></name><name><surname>Valiente</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling.</article-title>
<source/><italic>Nature.</italic>
<year>2010</year>;<volume>464</volume>(<issue>7293</issue>):<fpage>1376</fpage>–<lpage>80</lpage>.
<pub-id pub-id-type="doi">10.1038/nature08928</pub-id>
<pub-id pub-id-type="pmid">20393464</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/3382956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-129">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bateup</surname><given-names>HS</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name><name><surname>Denefrio</surname><given-names>CL</given-names></name><etal></etal></person-group>:
<article-title>Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.</article-title>
<source/><italic>Neuron.</italic>
<year>2013</year>;<volume>78</volume>(<issue>3</issue>):<fpage>510</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.017</pub-id>
<!--<pub-id pub-id-type="pmcid">3690324</pub-id>-->
<pub-id pub-id-type="pmid">23664616</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718008457">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-130">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallace</surname><given-names>ML</given-names></name><name><surname>Burette</surname><given-names>AC</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><etal></etal></person-group>:
<article-title>Maternal loss of
<italic>Ube3a</italic> produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects.</article-title>
<source/><italic>Neuron.</italic>
<year>2012</year>;<volume>74</volume>(<issue>5</issue>):<fpage>793</fpage>–<lpage>800</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.036</pub-id>
<!--<pub-id pub-id-type="pmcid">3372864</pub-id>-->
<pub-id pub-id-type="pmid">22681684</pub-id></mixed-citation>
</ref>
<ref id="ref-131">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>C</given-names></name><name><surname>Ha</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Shank3</italic>-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit.</article-title>
<source/><italic>Front Cell Neurosci.</italic>
<year>2015</year>;<volume>9</volume>:<fpage>94</fpage>.
<pub-id pub-id-type="doi">10.3389/fncel.2015.00094</pub-id>
<!--<pub-id pub-id-type="pmcid">4365696</pub-id>-->
<pub-id pub-id-type="pmid">25852484</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725427134">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-132">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Mah</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.</article-title>
<source/><italic>Nat Med.</italic>
<year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>566</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1038/nm.2330</pub-id>
<pub-id pub-id-type="pmid">21499268</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/10908963">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-133">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rivero</surname><given-names>O</given-names></name><name><surname>Selten</surname><given-names>MM</given-names></name><name><surname>Sich</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition.</article-title>
<source/><italic>Transl Psychiatry.</italic>
<year>2015</year>;<volume>5</volume>:<fpage>e655</fpage>.
<pub-id pub-id-type="doi">10.1038/tp.2015.152</pub-id>
<!--<pub-id pub-id-type="pmcid">4930129</pub-id>-->
<pub-id pub-id-type="pmid">26460479</pub-id></mixed-citation>
</ref>
<ref id="ref-134">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibson</surname><given-names>JR</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group>:
<article-title>Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2009</year>;<volume>29</volume>(<issue>44</issue>):<fpage>13883</fpage>–<lpage>97</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2457-09.2009</pub-id>
<!--<pub-id pub-id-type="pmcid">2814361</pub-id>-->
<pub-id pub-id-type="pmid">19889999</pub-id></mixed-citation>
</ref>
<ref id="ref-135">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poulopoulos</surname><given-names>A</given-names></name><name><surname>Aramuni</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin.</article-title>
<source/><italic>Neuron.</italic>
<year>2009</year>;<volume>63</volume>(<issue>5</issue>):<fpage>628</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.023</pub-id>
<pub-id pub-id-type="pmid">19755106</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1165169">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-136">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Földy</surname><given-names>C</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group>:
<article-title>Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling.</article-title>
<source/><italic>Neuron.</italic>
<year>2013</year>;<volume>78</volume>(<issue>3</issue>):<fpage>498</fpage>–<lpage>509</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.036</pub-id>
<!--<pub-id pub-id-type="pmcid">3663050</pub-id>-->
<pub-id pub-id-type="pmid">23583622</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718000134">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-137">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>GR</given-names></name><name><surname>Galfin</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2012</year>;<volume>109</volume>(<issue>44</issue>):<fpage>18120</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1216398109</pub-id>
<!--<pub-id pub-id-type="pmcid">3497786</pub-id>-->
<pub-id pub-id-type="pmid">23074245</pub-id></mixed-citation>
</ref>
<ref id="ref-138">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xue</surname><given-names>M</given-names></name><name><surname>Atallah</surname><given-names>BV</given-names></name><name><surname>Scanziani</surname><given-names>M</given-names></name></person-group>:
<article-title>Equalizing excitation-inhibition ratios across visual cortical neurons.</article-title>
<source/><italic>Nature.</italic>
<year>2014</year>;<volume>511</volume>(<issue>7511</issue>):<fpage>596</fpage>–<lpage>600</lpage>.
<pub-id pub-id-type="doi">10.1038/nature13321</pub-id>
<!--<pub-id pub-id-type="pmcid">4117808</pub-id>-->
<pub-id pub-id-type="pmid">25043046</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718513442">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-139">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tamás</surname><given-names>G</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name><name><surname>Lörincz</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2000</year>;<volume>3</volume>(<issue>4</issue>):<fpage>366</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1038/73936</pub-id>
<pub-id pub-id-type="pmid">10725926</pub-id></mixed-citation>
</ref>
<ref id="ref-140">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name></person-group>:
<article-title>The spatial and temporal origin of chandelier cells in mouse neocortex.</article-title>
<source/><italic>Science.</italic>
<year>2013</year>;<volume>339</volume>(<issue>6115</issue>):<fpage>70</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1227622</pub-id>
<!--<pub-id pub-id-type="pmcid">4017638</pub-id>-->
<pub-id pub-id-type="pmid">23180771</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717968338">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-141">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartos</surname><given-names>M</given-names></name><name><surname>Vida</surname><given-names>I</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name></person-group>:
<article-title>Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2007</year>;<volume>8</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>56</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn2044</pub-id>
<pub-id pub-id-type="pmid">17180162</pub-id></mixed-citation>
</ref>
<ref id="ref-142">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Kopell</surname><given-names>N</given-names></name><name><surname>Bibbig</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Gap junctions between interneuron dendrites can enhance synchrony of gamma oscillations in distributed networks.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2001</year>;<volume>21</volume>(<issue>23</issue>):<fpage>9478</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="pmid">11717382</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1003007">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-143">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mullins</surname><given-names>C</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group>:
<article-title>Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops.</article-title>
<source/><italic>Neuron.</italic>
<year>2016</year>;<volume>89</volume>(<issue>6</issue>):<fpage>1131</fpage>–<lpage>56</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.017</pub-id>
<pub-id pub-id-type="pmid">26985722</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726223403">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-144">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name><name><surname>Leslie</surname><given-names>KR</given-names></name><name><surname>Desai</surname><given-names>NS</given-names></name><etal></etal></person-group>:
<article-title>Activity-dependent scaling of quantal amplitude in neocortical neurons.</article-title>
<source/><italic>Nature.</italic>
<year>1998</year>;<volume>391</volume>(<issue>6670</issue>):<fpage>892</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1038/36103</pub-id>
<pub-id pub-id-type="pmid">9495341</pub-id></mixed-citation>
</ref>
<ref id="ref-145">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kilman</surname><given-names>V</given-names></name><name><surname>van Rossum</surname><given-names>MC</given-names></name><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group>:
<article-title>Activity deprivation reduces miniature IPSC amplitude by decreasing the number of postsynaptic GABA(A) receptors clustered at neocortical synapses.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2002</year>;<volume>22</volume>(<issue>4</issue>):<fpage>1328</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="pmid">11850460</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/719882438">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-146">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Desai</surname><given-names>NS</given-names></name><name><surname>Rutherford</surname><given-names>LC</given-names></name><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group>:
<article-title>Plasticity in the intrinsic excitability of cortical pyramidal neurons.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>1999</year>;<volume>2</volume>(<issue>6</issue>):<fpage>515</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1038/9165</pub-id>
<pub-id pub-id-type="pmid">10448215</pub-id></mixed-citation>
</ref>
<ref id="ref-147">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartley</surname><given-names>AF</given-names></name><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name><etal></etal></person-group>:
<article-title>Differential activity-dependent, homeostatic plasticity of two neocortical inhibitory circuits.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2008</year>;<volume>100</volume>(<issue>4</issue>):<fpage>1983</fpage>–<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.90635.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2576194</pub-id>-->
<pub-id pub-id-type="pmid">18701752</pub-id></mixed-citation>
</ref>
<ref id="ref-148">
<label>148</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Echegoyen</surname><given-names>J</given-names></name><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Graber</surname><given-names>KD</given-names></name><etal></etal></person-group>:
<article-title>Homeostatic plasticity studied using
<italic>in vivo</italic> hippocampal activity-blockade: synaptic scaling, intrinsic plasticity and age-dependence.</article-title>
<source/><italic>PLoS One.</italic>
<year>2007</year>;<volume>2</volume>(<issue>8</issue>):<fpage>e700</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0000700</pub-id>
<!--<pub-id pub-id-type="pmcid">1933594</pub-id>-->
<pub-id pub-id-type="pmid">17684547</pub-id></mixed-citation>
</ref>
<ref id="ref-149">
<label>149</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Norton</surname><given-names>N</given-names></name><name><surname>Moskvina</surname><given-names>V</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name><etal></etal></person-group>:
<article-title>Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.</article-title>
<source/><italic>Am J Med Genet B Neuropsychiatr Genet.</italic>
<year>2006</year>;<volume>141B</volume>(<issue>1</issue>):<fpage>96</fpage>–<lpage>101</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.b.30236</pub-id>
<pub-id pub-id-type="pmid">16249994</pub-id></mixed-citation>
</ref>
<ref id="ref-150">
<label>150</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silberberg</surname><given-names>G</given-names></name><name><surname>Darvasi</surname><given-names>A</given-names></name><name><surname>Pinkas-Kramarski</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>The involvement of
<italic>ErbB4</italic> with schizophrenia: association and expression studies.</article-title>
<source/><italic>Am J Med Genet B Neuropsychiatr Genet.</italic>
<year>2006</year>;<volume>141B</volume>(<issue>2</issue>):<fpage>142</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.b.30275</pub-id>
<pub-id pub-id-type="pmid">16402353</pub-id></mixed-citation>
</ref>
<ref id="ref-151">
<label>151</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vullhorst</surname><given-names>D</given-names></name><name><surname>Neddens</surname><given-names>J</given-names></name><name><surname>Karavanova</surname><given-names>I</given-names></name><etal></etal></person-group>:
<article-title>Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2009</year>;<volume>29</volume>(<issue>39</issue>):<fpage>12255</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2454-09.2009</pub-id>
<!--<pub-id pub-id-type="pmcid">2774835</pub-id>-->
<pub-id pub-id-type="pmid">19793984</pub-id></mixed-citation>
</ref>
<ref id="ref-152">
<label>152</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woo</surname><given-names>RS</given-names></name><name><surname>Li</surname><given-names>XM</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Neuregulin-1 enhances depolarization-induced GABA release.</article-title>
<source/><italic>Neuron.</italic>
<year>2007</year>;<volume>54</volume>(<issue>4</issue>):<fpage>599</fpage>–<lpage>610</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.04.009</pub-id>
<pub-id pub-id-type="pmid">17521572</pub-id></mixed-citation>
</ref>
<ref id="ref-153">
<label>153</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Sigurdsson</surname><given-names>E</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Neuregulin 1</italic> and susceptibility to schizophrenia.</article-title>
<source/><italic>Am J Hum Genet.</italic>
<year>2002</year>;<volume>71</volume>(<issue>4</issue>):<fpage>877</fpage>–<lpage>92</lpage>.
<pub-id pub-id-type="doi">10.1086/342734</pub-id>
<!--<pub-id pub-id-type="pmcid">378543</pub-id>-->
<pub-id pub-id-type="pmid">12145742</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1011019">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-154">
<label>154</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Georgieva</surname><given-names>L</given-names></name><name><surname>Dimitrova</surname><given-names>A</given-names></name><name><surname>Ivanov</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia.</article-title>
<source/><italic>Biol Psychiatry.</italic>
<year>2008</year>;<volume>64</volume>(<issue>5</issue>):<fpage>419</fpage>–<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1016/j.biopsych.2008.03.025</pub-id>
<pub-id pub-id-type="pmid">18466881</pub-id></mixed-citation>
</ref>
<ref id="ref-155">
<label>155</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prata</surname><given-names>DP</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Osborne</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis.</article-title>
<source/><italic>Psychiatr Genet.</italic>
<year>2009</year>;<volume>19</volume>(<issue>3</issue>):<fpage>113</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1097/YPG.0b013e32832a4f69</pub-id>
<pub-id pub-id-type="pmid">19339916</pub-id></mixed-citation>
</ref>
<ref id="ref-156">
<label>156</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>AJ</given-names></name><name><surname>Pieretti</surname><given-names>M</given-names></name><name><surname>Sutcliffe</surname><given-names>JS</given-names></name><etal></etal></person-group>:
<article-title>Identification of a gene (
<italic>FMR-1</italic>) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.</article-title>
<source/><italic>Cell.</italic>
<year>1991</year>;<volume>65</volume>(<issue>5</issue>):<fpage>905</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-H</pub-id>
<pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="ref-157">
<label>157</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>WE</given-names></name><name><surname>Cortell</surname><given-names>R</given-names></name><name><surname>Kau</surname><given-names>AS</given-names></name><etal></etal></person-group>:
<article-title>Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors.</article-title>
<source/><italic>Am J Med Genet A.</italic>
<year>2004</year>;<volume>129A</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.30229</pub-id>
<pub-id pub-id-type="pmid">15326621</pub-id></mixed-citation>
</ref>
<ref id="ref-158">
<label>158</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name><name><surname>Warren</surname><given-names>ST</given-names></name></person-group>:
<article-title>The mGluR theory of fragile X mental retardation.</article-title>
<source/><italic>Trends Neurosci.</italic>
<year>2004</year>;<volume>27</volume>(<issue>7</issue>):<fpage>370</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15219735</pub-id></mixed-citation>
</ref>
<ref id="ref-159">
<label>159</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paluszkiewicz</surname><given-names>SM</given-names></name><name><surname>Martin</surname><given-names>BS</given-names></name><name><surname>Huntsman</surname><given-names>MM</given-names></name></person-group>:
<article-title>Fragile X syndrome: the GABAergic system and circuit dysfunction.</article-title>
<source/><italic>Dev Neurosci.</italic>
<year>2011</year>;<volume>33</volume>(<issue>5</issue>):<fpage>349</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1159/000329420</pub-id>
<!--<pub-id pub-id-type="pmcid">3254035</pub-id>-->
<pub-id pub-id-type="pmid">21934270</pub-id></mixed-citation>
</ref>
<ref id="ref-160">
<label>160</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cea-Del Rio</surname><given-names>CA</given-names></name><name><surname>Huntsman</surname><given-names>MM</given-names></name></person-group>:
<article-title>The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome.</article-title>
<source/><italic>Front Cell Neurosci.</italic>
<year>2014</year>;<volume>8</volume>:<fpage>245</fpage>.
<pub-id pub-id-type="doi">10.3389/fncel.2014.00245</pub-id>
<!--<pub-id pub-id-type="pmcid">4142705</pub-id>-->
<pub-id pub-id-type="pmid">25202236</pub-id></mixed-citation>
</ref>
<ref id="ref-161">
<label>161</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D'Hulst</surname><given-names>C</given-names></name><name><surname>De Geest</surname><given-names>N</given-names></name><name><surname>Reeve</surname><given-names>SP</given-names></name><etal></etal></person-group>:
<article-title>Decreased expression of the GABA
<sub>A</sub> receptor in fragile X syndrome.</article-title>
<source/><italic>Brain Res.</italic>
<year>2006</year>;<volume>1121</volume>(<issue>1</issue>):<fpage>238</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1016/j.brainres.2006.08.115</pub-id>
<pub-id pub-id-type="pmid">17046729</pub-id></mixed-citation>
</ref>
<ref id="ref-162">
<label>162</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selby</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>QQ</given-names></name></person-group>:
<article-title>Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.</article-title>
<source/><italic>Neurosci Lett.</italic>
<year>2007</year>;<volume>412</volume>(<issue>3</issue>):<fpage>227</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neulet.2006.11.062</pub-id>
<!--<pub-id pub-id-type="pmcid">1839948</pub-id>-->
<pub-id pub-id-type="pmid">17197085</pub-id></mixed-citation>
</ref>
<ref id="ref-163">
<label>163</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gatto</surname><given-names>CL</given-names></name><name><surname>Broadie</surname><given-names>K</given-names></name></person-group>:
<article-title>Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.</article-title>
<source/><italic>Front Synaptic Neurosci.</italic>
<year>2010</year>;<volume>2</volume>:<fpage>4</fpage>.
<pub-id pub-id-type="doi">10.3389/fnsyn.2010.00004</pub-id>
<!--<pub-id pub-id-type="pmcid">3059704</pub-id>-->
<pub-id pub-id-type="pmid">21423490</pub-id></mixed-citation>
</ref>
<ref id="ref-164">
<label>164</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>BS</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2015</year>;<volume>112</volume>(<issue>34</issue>):<fpage>E4782</fpage>–<lpage>91</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1506499112</pub-id>
<!--<pub-id pub-id-type="pmcid">4553776</pub-id>-->
<pub-id pub-id-type="pmid">26261347</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725713136">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-165">
<label>165</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hensch</surname><given-names>TK</given-names></name></person-group>:
<article-title>Critical period plasticity in local cortical circuits.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2005</year>;<volume>6</volume>(<issue>11</issue>):<fpage>877</fpage>–<lpage>88</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn1787</pub-id>
<pub-id pub-id-type="pmid">16261181</pub-id></mixed-citation>
</ref>
<ref id="ref-166">
<label>166</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marín</surname><given-names>O</given-names></name></person-group>:
<article-title>Developmental timing and critical windows for the treatment of psychiatric disorders.</article-title>
<source/><italic>Nat Med.</italic>
<year>2016</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1229</fpage>–<lpage>38</lpage>.
<pub-id pub-id-type="doi">10.1038/nm.4225</pub-id>
<pub-id pub-id-type="pmid">27783067</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726887740">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-167">
<label>167</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chao</surname><given-names>HT</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Samaco</surname><given-names>RC</given-names></name><etal></etal></person-group>:
<article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.</article-title>
<source/><italic>Nature.</italic>
<year>2010</year>;<volume>468</volume>(<issue>7321</issue>):<fpage>263</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nature09582</pub-id>
<!--<pub-id pub-id-type="pmcid">3057962</pub-id>-->
<pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718560875">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-168">
<label>168</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito-Ishida</surname><given-names>A</given-names></name><name><surname>Ure</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes.</article-title>
<source/><italic>Neuron.</italic>
<year>2015</year>;<volume>88</volume>(<issue>4</issue>):<fpage>651</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.029</pub-id>
<!--<pub-id pub-id-type="pmcid">4656196</pub-id>-->
<pub-id pub-id-type="pmid">26590342</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725951405">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-169">
<label>169</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Rikhye</surname><given-names>RV</given-names></name><name><surname>Breton-Provencher</surname><given-names>V</given-names></name><etal></etal></person-group>:
<article-title>Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2016</year>;<volume>113</volume>(<issue>46</issue>):<fpage>E7287</fpage>–<lpage>E7296</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1615330113</pub-id>
<!--<pub-id pub-id-type="pmcid">5135376</pub-id>-->
<pub-id pub-id-type="pmid">27803317</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726914728">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-170">
<label>170</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dehorter</surname><given-names>N</given-names></name><name><surname>Marichal</surname><given-names>N</given-names></name><name><surname>Marín</surname><given-names>O</given-names></name><etal></etal></person-group>:
<article-title>Tuning neural circuits by turning the interneuron knob.</article-title>
<source/><italic>Curr Opin Neurobiol.</italic>
<year>2017</year>;<volume>42</volume>:<fpage>144</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2016.12.009</pub-id>
<pub-id pub-id-type="pmid">28088067</pub-id></mixed-citation>
</ref>
<ref id="ref-171">
<label>171</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beck</surname><given-names>H</given-names></name><name><surname>Yaari</surname><given-names>Y</given-names></name></person-group>:
<article-title>Plasticity of intrinsic neuronal properties in CNS disorders.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2008</year>;<volume>9</volume>(<issue>5</issue>):<fpage>357</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn2371</pub-id>
<pub-id pub-id-type="pmid">18425090</pub-id></mixed-citation>
</ref>
<ref id="ref-172">
<label>172</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Straub</surname><given-names>RE</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>MacLean</surname><given-names>CJ</given-names></name><etal></etal></person-group>:
<article-title>Genetic variation in the 6p22.3 gene
<italic>DTNBP1</italic>, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.</article-title>
<source/><italic>Am J Hum Genet.</italic>
<year>2002</year>;<volume>71</volume>(<issue>2</issue>):<fpage>337</fpage>–<lpage>48</lpage>.
<pub-id pub-id-type="doi">10.1086/341750</pub-id>
<!--<pub-id pub-id-type="pmcid">379166</pub-id>-->
<pub-id pub-id-type="pmid">12098102</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1011016">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-173">
<label>173</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carlson</surname><given-names>GC</given-names></name><name><surname>Talbot</surname><given-names>K</given-names></name><name><surname>Halene</surname><given-names>TB</given-names></name><etal></etal></person-group>:
<article-title>Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2011</year>;<volume>108</volume>(<issue>43</issue>):<fpage>E962</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1109625108</pub-id>
<!--<pub-id pub-id-type="pmcid">3203764</pub-id>-->
<pub-id pub-id-type="pmid">21969553</pub-id></mixed-citation>
</ref>
<ref id="ref-174">
<label>174</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larimore</surname><given-names>J</given-names></name><name><surname>Zlatic</surname><given-names>SA</given-names></name><name><surname>Arnold</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.</article-title>
<source/><italic>Front Genet.</italic>
<year>2017</year>;<volume>8</volume>:<fpage>28</fpage>.
<pub-id pub-id-type="doi">10.3389/fgene.2017.00028</pub-id>
<!--<pub-id pub-id-type="pmcid">5344932</pub-id>-->
<pub-id pub-id-type="pmid">28344592</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727448322">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-175">
<label>175</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>BM</given-names></name><name><surname>Liu</surname><given-names>XR</given-names></name><name><surname>Yi</surname><given-names>YH</given-names></name><etal></etal></person-group>:
<article-title>Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<year>2011</year>;<volume>21</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1016/j.yebeh.2011.04.060</pub-id>
<pub-id pub-id-type="pmid">21620773</pub-id></mixed-citation>
</ref>
<ref id="ref-176">
<label>176</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Roak</surname><given-names>BJ</given-names></name><name><surname>Deriziotis</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe
<italic>de novo</italic> mutations.</article-title>
<source/><italic>Nat Genet.</italic>
<year>2011</year>;<volume>43</volume>(<issue>6</issue>):<fpage>585</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/ng.835</pub-id>
<!--<pub-id pub-id-type="pmcid">3115696</pub-id>-->
<pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/10819956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-177">
<label>177</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Wart</surname><given-names>A</given-names></name><name><surname>Trimmer</surname><given-names>JS</given-names></name><name><surname>Matthews</surname><given-names>G</given-names></name></person-group>:
<article-title>Polarized distribution of ion channels within microdomains of the axon initial segment.</article-title>
<source/><italic>J Comp Neurol.</italic>
<year>2007</year>;<volume>500</volume>(<issue>2</issue>):<fpage>339</fpage>–<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.1002/cne.21173</pub-id>
<pub-id pub-id-type="pmid">17111377</pub-id></mixed-citation>
</ref>
<ref id="ref-178">
<label>178</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kole</surname><given-names>MH</given-names></name><name><surname>Stuart</surname><given-names>GJ</given-names></name></person-group>:
<article-title>Signal processing in the axon initial segment.</article-title>
<source/><italic>Neuron.</italic>
<year>2012</year>;<volume>73</volume>(<issue>2</issue>):<fpage>235</fpage>–<lpage>47</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.01.007</pub-id>
<pub-id pub-id-type="pmid">22284179</pub-id></mixed-citation>
</ref>
<ref id="ref-179">
<label>179</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheah</surname><given-names>CS</given-names></name><name><surname>Yu</surname><given-names>FH</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><etal></etal></person-group>:
<article-title>Specific deletion of Na
<sub>V</sub>1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2012</year>;<volume>109</volume>(<issue>36</issue>):<fpage>14646</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1211591109</pub-id>
<!--<pub-id pub-id-type="pmcid">3437823</pub-id>-->
<pub-id pub-id-type="pmid">22908258</pub-id></mixed-citation>
</ref>
<ref id="ref-180">
<label>180</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dutton</surname><given-names>SB</given-names></name><name><surname>Makinson</surname><given-names>CD</given-names></name><name><surname>Papale</surname><given-names>LA</given-names></name><etal></etal></person-group>:
<article-title>Preferential inactivation of
<italic>Scn1a</italic> in parvalbumin interneurons increases seizure susceptibility.</article-title>
<source/><italic>Neurobiol Dis.</italic>
<year>2013</year>;<volume>49</volume>:<fpage>211</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1016/j.nbd.2012.08.012</pub-id>
<!--<pub-id pub-id-type="pmcid">3740063</pub-id>-->
<pub-id pub-id-type="pmid">22926190</pub-id></mixed-citation>
</ref>
<ref id="ref-181">
<label>181</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Tai</surname><given-names>C</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><etal></etal></person-group>:
<article-title>Autistic-like behaviour in
<italic>Scn1a</italic>
<sup>+/-</sup> mice and rescue by enhanced GABA-mediated neurotransmission.</article-title>
<source/><italic>Nature.</italic>
<year>2012</year>;<volume>489</volume>(<issue>7416</issue>):<fpage>385</fpage>–<lpage>90</lpage>.
<pub-id pub-id-type="doi">10.1038/nature11356</pub-id>
<!--<pub-id pub-id-type="pmcid">3448848</pub-id>-->
<pub-id pub-id-type="pmid">22914087</pub-id></mixed-citation>
</ref>
<ref id="ref-182">
<label>182</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stedehouder</surname><given-names>J</given-names></name><name><surname>Kushner</surname><given-names>SA</given-names></name></person-group>:
<article-title>Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia.</article-title>
<source/><italic>Mol Psychiatry.</italic>
<year>2017</year>;<volume>22</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2016.147</pub-id>
<!--<pub-id pub-id-type="pmcid">5414080</pub-id>-->
<pub-id pub-id-type="pmid">27646261</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726760590">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-183">
<label>183</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>White</surname><given-names>T</given-names></name><name><surname>Magnotta</surname><given-names>VA</given-names></name><name><surname>Bockholt</surname><given-names>HJ</given-names></name><etal></etal></person-group>:
<article-title>Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study.</article-title>
<source/><italic>Schizophr Bull.</italic>
<year>2011</year>;<volume>37</volume>(<issue>1</issue>):<fpage>222</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1093/schbul/sbp088</pub-id>
<!--<pub-id pub-id-type="pmcid">3004177</pub-id>-->
<pub-id pub-id-type="pmid">19770491</pub-id></mixed-citation>
</ref>
<ref id="ref-184">
<label>184</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uranova</surname><given-names>NA</given-names></name><name><surname>Vostrikov</surname><given-names>VM</given-names></name><name><surname>Orlovskaya</surname><given-names>DD</given-names></name><etal></etal></person-group>:
<article-title>Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.</article-title>
<source/><italic>Schizophr Res.</italic>
<year>2004</year>;<volume>67</volume>(<issue>2–3</issue>):<fpage>269</fpage>–<lpage>75</lpage>.
<pub-id pub-id-type="doi">10.1016/S0920-9964(03)00181-6</pub-id>
<pub-id pub-id-type="pmid">14984887</pub-id></mixed-citation>
</ref>
<ref id="ref-185">
<label>185</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hakak</surname><given-names>Y</given-names></name><name><surname>Walker</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2001</year>;<volume>98</volume>(<issue>8</issue>):<fpage>4746</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.081071198</pub-id>
<!--<pub-id pub-id-type="pmcid">31905</pub-id>-->
<pub-id pub-id-type="pmid">11296301</pub-id></mixed-citation>
</ref>
<ref id="ref-186">
<label>186</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katsumaru</surname><given-names>H</given-names></name><name><surname>Kosaka</surname><given-names>T</given-names></name><name><surname>Heizmann</surname><given-names>CW</given-names></name><etal></etal></person-group>:
<article-title>Immunocytochemical study of GABAergic neurons containing the calcium-binding protein parvalbumin in the rat hippocampus.</article-title>
<source/><italic>Exp Brain Res.</italic>
<year>1988</year>;<volume>72</volume>(<issue>2</issue>):<fpage>347</fpage>–<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1007/BF00250256</pub-id>
<pub-id pub-id-type="pmid">3066634</pub-id></mixed-citation>
</ref>
<ref id="ref-187">
<label>187</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Micheva</surname><given-names>KD</given-names></name><name><surname>Wolman</surname><given-names>D</given-names></name><name><surname>Mensh</surname><given-names>BD</given-names></name><etal></etal></person-group>:
<article-title>A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons.</article-title>
<source/><italic>eLife.</italic>
<year>2016</year>;<volume>5</volume>: pii: e15784.
<pub-id pub-id-type="doi">10.7554/eLife.15784</pub-id>
<!--<pub-id pub-id-type="pmcid">4972537</pub-id>-->
<pub-id pub-id-type="pmid">27383052</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726488452">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-188">
<label>188</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chung</surname><given-names>K</given-names></name><name><surname>Wallace</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><etal></etal></person-group>:
<article-title>Structural and molecular interrogation of intact biological systems.</article-title>
<source/><italic>Nature.</italic>
<year>2013</year>;<volume>497</volume>(<issue>7449</issue>):<fpage>332</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12107</pub-id>
<!--<pub-id pub-id-type="pmcid">4092167</pub-id>-->
<pub-id pub-id-type="pmid">23575631</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717999296">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-189">
<label>189</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name></person-group>:
<article-title>Myelination of the nervous system: mechanisms and functions.</article-title>
<source/><italic>Annu Rev Cell Dev Biol.</italic>
<year>2014</year>;<volume>30</volume>:<fpage>503</fpage>–<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013101</pub-id>
<pub-id pub-id-type="pmid">25288117</pub-id></mixed-citation>
</ref>
<ref id="ref-190">
<label>190</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group>:
<article-title>The chandelier neuron in schizophrenia.</article-title>
<source/><italic>Dev Neurobiol.</italic>
<year>2011</year>;<volume>71</volume>(<issue>1</issue>):<fpage>118</fpage>–<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1002/dneu.20825</pub-id>
<!--<pub-id pub-id-type="pmcid">3116957</pub-id>-->
<pub-id pub-id-type="pmid">21154915</pub-id></mixed-citation>
</ref>
<ref id="ref-191">
<label>191</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Del Pino</surname><given-names>I</given-names></name><name><surname>Brotons-Mas</surname><given-names>JR</given-names></name><name><surname>Marques-Smith</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Abnormal wiring of CCK
<sup>+</sup> basket cells disrupts spatial information coding.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2017</year>;<volume>20</volume>(<issue>6</issue>):<fpage>784</fpage>–<lpage>92</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.4544</pub-id>
<!--<pub-id pub-id-type="pmcid">5446788</pub-id>-->
<pub-id pub-id-type="pmid">28394324</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727493767">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-192">
<label>192</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prather</surname><given-names>P</given-names></name><name><surname>de Vries</surname><given-names>PJ</given-names></name></person-group>:
<article-title>Behavioral and cognitive aspects of tuberous sclerosis complex.</article-title>
<source/><italic>J Child Neurol.</italic>
<year>2004</year>;<volume>19</volume>(<issue>9</issue>):<fpage>666</fpage>–<lpage>74</lpage>.
<pub-id pub-id-type="doi">10.1177/08830738040190090601</pub-id>
<pub-id pub-id-type="pmid">15563012</pub-id></mixed-citation>
</ref>
<ref id="ref-193">
<label>193</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>AC</given-names></name><name><surname>Shyamsundar</surname><given-names>MM</given-names></name><name><surname>Thomas</surname><given-names>MW</given-names></name><etal></etal></person-group>:
<article-title>Comprehensive mutation analysis of
<italic>TSC1</italic> and
<italic>TSC2</italic>-and phenotypic correlations in 150 families with tuberous sclerosis.</article-title>
<source/><italic>Am J Hum Genet.</italic>
<year>1999</year>;<volume>64</volume>(<issue>5</issue>):<fpage>1305</fpage>–<lpage>15</lpage>.
<pub-id pub-id-type="doi">10.1086/302381</pub-id>
<!--<pub-id pub-id-type="pmcid">1377866</pub-id>-->
<pub-id pub-id-type="pmid">10205261</pub-id></mixed-citation>
</ref>
<ref id="ref-194">
<label>194</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rougeulle</surname><given-names>C</given-names></name><name><surname>Glatt</surname><given-names>H</given-names></name><name><surname>Lalande</surname><given-names>M</given-names></name></person-group>:
<article-title>The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain.</article-title>
<source/><italic>Nat Genet.</italic>
<year>1997</year>;<volume>17</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1038/ng0997-14</pub-id>
<pub-id pub-id-type="pmid">9288088</pub-id></mixed-citation>
</ref>
<ref id="ref-195">
<label>195</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>CA</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Angelman syndrome 2005: updated consensus for diagnostic criteria.</article-title>
<source/><italic>Am J Med Genet A.</italic>
<year>2006</year>;<volume>140</volume>(<issue>5</issue>):<fpage>413</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.31074</pub-id>
<pub-id pub-id-type="pmid">16470747</pub-id></mixed-citation>
</ref>
<ref id="ref-196">
<label>196</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thibert</surname><given-names>RL</given-names></name><name><surname>Conant</surname><given-names>KD</given-names></name><name><surname>Braun</surname><given-names>EK</given-names></name><etal></etal></person-group>:
<article-title>Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2009</year>;<volume>50</volume>(<issue>11</issue>):<fpage>2369</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02108.x</pub-id>
<pub-id pub-id-type="pmid">19453717</pub-id></mixed-citation>
</ref>
<ref id="ref-197">
<label>197</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>YH</given-names></name><name><surname>Armstrong</surname><given-names>D</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><etal></etal></person-group>:
<article-title>Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.</article-title>
<source/><italic>Neuron.</italic>
<year>1998</year>;<volume>21</volume>(<issue>4</issue>):<fpage>799</fpage>–<lpage>811</lpage>.
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80596-6</pub-id>
<pub-id pub-id-type="pmid">9808466</pub-id></mixed-citation>
</ref>
<ref id="ref-198">
<label>198</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>K</given-names></name><name><surname>Riday</surname><given-names>TT</given-names></name><name><surname>Condon</surname><given-names>KH</given-names></name><etal></etal></person-group>:
<article-title>Ube3a is required for experience-dependent maturation of the neocortex.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2009</year>;<volume>12</volume>(<issue>6</issue>):<fpage>777</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.2327</pub-id>
<!--<pub-id pub-id-type="pmcid">2741303</pub-id>-->
<pub-id pub-id-type="pmid">19430469</pub-id></mixed-citation>
</ref>
<ref id="ref-199">
<label>199</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Judson</surname><given-names>MC</given-names></name><name><surname>Wallace</surname><given-names>ML</given-names></name><name><surname>Sidorov</surname><given-names>MS</given-names></name><etal></etal></person-group>:
<article-title>GABAergic Neuron-Specific Loss of
<italic>Ube3a</italic> Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.</article-title>
<source/><italic>Neuron.</italic>
<year>2016</year>;<volume>90</volume>(<issue>1</issue>):<fpage>56</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.040</pub-id>
<!--<pub-id pub-id-type="pmcid">4824651</pub-id>-->
<pub-id pub-id-type="pmid">27021170</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726252169">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-200">
<label>200</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallace</surname><given-names>ML</given-names></name><name><surname>van Woerden</surname><given-names>GM</given-names></name><name><surname>Elgersma</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Ube3a</italic> loss increases excitability and blunts orientation tuning in the visual cortex of Angelman syndrome model mice.</article-title>
<source/><italic>J Neurophysiol.</italic>
<year>2017</year>;<volume>118</volume>(<issue>1</issue>):<fpage>634</fpage>–<lpage>46</lpage>.
<pub-id pub-id-type="doi">10.1152/jn.00618.2016</pub-id>
<!--<pub-id pub-id-type="pmcid">5511875</pub-id>-->
<pub-id pub-id-type="pmid">28468997</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727583264">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-201">
<label>201</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atallah</surname><given-names>BV</given-names></name><name><surname>Bruns</surname><given-names>W</given-names></name><name><surname>Carandini</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Parvalbumin-expressing interneurons linearly transform cortical responses to visual stimuli.</article-title>
<source/><italic>Neuron.</italic>
<year>2012</year>;<volume>73</volume>(<issue>1</issue>):<fpage>159</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.013</pub-id>
<!--<pub-id pub-id-type="pmcid">3743079</pub-id>-->
<pub-id pub-id-type="pmid">22243754</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/13830966">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-202">
<label>202</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilson</surname><given-names>NR</given-names></name><name><surname>Runyan</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>FL</given-names></name><etal></etal></person-group>:
<article-title>Division and subtraction by distinct cortical inhibitory networks
<italic>in vivo</italic>.</article-title>
<source/><italic>Nature.</italic>
<year>2012</year>;<volume>488</volume>(<issue>7411</issue>):<fpage>343</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/nature11347</pub-id>
<!--<pub-id pub-id-type="pmcid">3653570</pub-id>-->
<pub-id pub-id-type="pmid">22878717</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717953920">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-203">
<label>203</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leblond</surname><given-names>CS</given-names></name><name><surname>Nava</surname><given-names>C</given-names></name><name><surname>Polge</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Meta-analysis of
<italic>SHANK</italic> Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.</article-title>
<source/><italic>PLoS Genet.</italic>
<year>2014</year>;<volume>10</volume>(<issue>9</issue>):<fpage>e1004580</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004580</pub-id>
<!--<pub-id pub-id-type="pmcid">4154644</pub-id>-->
<pub-id pub-id-type="pmid">25188300</pub-id></mixed-citation>
</ref>
<ref id="ref-204">
<label>204</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name></person-group>:
<article-title>SHANK proteins: roles at the synapse and in autism spectrum disorder.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2017</year>;<volume>18</volume>(<issue>3</issue>):<fpage>147</fpage>–<lpage>57</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn.2016.183</pub-id>
<pub-id pub-id-type="pmid">28179641</pub-id></mixed-citation>
</ref>
<ref id="ref-205">
<label>205</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Naisbitt</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Tu</surname><given-names>JC</given-names></name><etal></etal></person-group>:
<article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin.</article-title>
<source/><italic>Neuron.</italic>
<year>1999</year>;<volume>23</volume>(<issue>3</issue>):<fpage>569</fpage>–<lpage>82</lpage>.
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80809-0</pub-id>
<pub-id pub-id-type="pmid">10433268</pub-id></mixed-citation>
</ref>
<ref id="ref-206">
<label>206</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tao-Cheng</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Reese</surname><given-names>TS</given-names></name><etal></etal></person-group>:
<article-title>Differential distribution of Shank and GKAP at the postsynaptic density.</article-title>
<source/><italic>PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e0118750</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0118750</pub-id>
<!--<pub-id pub-id-type="pmcid">4361712</pub-id>-->
<pub-id pub-id-type="pmid">25775468</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725390297">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-207">
<label>207</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peça</surname><given-names>J</given-names></name><name><surname>Feliciano</surname><given-names>C</given-names></name><name><surname>Ting</surname><given-names>JT</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Shank3</italic> mutant mice display autistic-like behaviours and striatal dysfunction.</article-title>
<source/><italic>Nature.</italic>
<year>2011</year>;<volume>472</volume>(<issue>7344</issue>):<fpage>437</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1038/nature09965</pub-id>
<!--<pub-id pub-id-type="pmcid">3090611</pub-id>-->
<pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/9869956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-208">
<label>208</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bozdagi</surname><given-names>O</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Papapetrou</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Haploinsufficiency of the autism-associated
<italic>Shank3</italic> gene leads to deficits in synaptic function, social interaction, and social communication.</article-title>
<source/><italic>Mol Autism.</italic>
<year>2010</year>;<volume>1</volume>(<issue>1</issue>):<fpage>15</fpage>.
<pub-id pub-id-type="doi">10.1186/2040-2392-1-15</pub-id>
<!--<pub-id pub-id-type="pmcid">3019144</pub-id>-->
<pub-id pub-id-type="pmid">21167025</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/10696961">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-209">
<label>209</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>McCoy</surname><given-names>PA</given-names></name><name><surname>Rodriguiz</surname><given-names>RM</given-names></name><etal></etal></person-group>:
<article-title>Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of
<italic>Shank3</italic>.</article-title>
<source/><italic>Hum Mol Genet.</italic>
<year>2011</year>;<volume>20</volume>(<issue>15</issue>):<fpage>3093</fpage>–<lpage>108</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddr212</pub-id>
<!--<pub-id pub-id-type="pmcid">3131048</pub-id>-->
<pub-id pub-id-type="pmid">21558424</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/10554956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-210">
<label>210</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group>:
<article-title>Neuroligins and neurexins link synaptic function to cognitive disease.</article-title>
<source/><italic>Nature.</italic>
<year>2008</year>;<volume>455</volume>(<issue>7215</issue>):<fpage>903</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1038/nature07456</pub-id>
<!--<pub-id pub-id-type="pmcid">2673233</pub-id>-->
<pub-id pub-id-type="pmid">18923512</pub-id></mixed-citation>
</ref>
<ref id="ref-211">
<label>211</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chih</surname><given-names>B</given-names></name><name><surname>Engelman</surname><given-names>H</given-names></name><name><surname>Scheiffele</surname><given-names>P</given-names></name></person-group>:
<article-title>Control of excitatory and inhibitory synapse formation by neuroligins.</article-title>
<source/><italic>Science.</italic>
<year>2005</year>;<volume>307</volume>(<issue>5713</issue>):<fpage>1324</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1107470</pub-id>
<pub-id pub-id-type="pmid">15681343</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1023860">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-212">
<label>212</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Ichtchenko</surname><given-names>K</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><etal></etal></person-group>:
<article-title>Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>1999</year>;<volume>96</volume>(<issue>3</issue>):<fpage>1100</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.96.3.1100</pub-id>
<!--<pub-id pub-id-type="pmcid">15357</pub-id>-->
<pub-id pub-id-type="pmid">9927700</pub-id></mixed-citation>
</ref>
<ref id="ref-213">
<label>213</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Jamain</surname><given-names>S</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group>:
<article-title>Neuroligin 2 is exclusively localized to inhibitory synapses.</article-title>
<source/><italic>Eur J Cell Biol.</italic>
<year>2004</year>;<volume>83</volume>(<issue>9</issue>):<fpage>449</fpage>–<lpage>56</lpage>.
<pub-id pub-id-type="doi">10.1078/0171-9335-00410</pub-id>
<pub-id pub-id-type="pmid">15540461</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1022877">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-214">
<label>214</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Budreck</surname><given-names>EC</given-names></name><name><surname>Scheiffele</surname><given-names>P</given-names></name></person-group>:
<article-title>Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.</article-title>
<source/><italic>Eur J Neurosci.</italic>
<year>2007</year>;<volume>26</volume>(<issue>7</issue>):<fpage>1738</fpage>–<lpage>48</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05842.x</pub-id>
<pub-id pub-id-type="pmid">17897391</pub-id></mixed-citation>
</ref>
<ref id="ref-215">
<label>215</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoon</surname><given-names>M</given-names></name><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Falkenburger</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2011</year>;<volume>108</volume>(<issue>7</issue>):<fpage>3053</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1006946108</pub-id>
<!--<pub-id pub-id-type="pmcid">3041141</pub-id>-->
<pub-id pub-id-type="pmid">21282647</pub-id></mixed-citation>
</ref>
<ref id="ref-216">
<label>216</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S</given-names></name><name><surname>Quach</surname><given-names>H</given-names></name><name><surname>Betancur</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat Genet.</italic>
<year>2003</year>;<volume>34</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<!--<pub-id pub-id-type="pmcid">1925054</pub-id>-->
<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1013538">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-217">
<label>217</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K</given-names></name><name><surname>Blundell</surname><given-names>J</given-names></name><name><surname>Etherton</surname><given-names>MR</given-names></name><etal></etal></person-group>:
<article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.</article-title>
<source/><italic>Science.</italic>
<year>2007</year>;<volume>318</volume>(<issue>5847</issue>):<fpage>71</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1146221</pub-id>
<!--<pub-id pub-id-type="pmcid">3235367</pub-id>-->
<pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1091788">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-218">
<label>218</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammer</surname><given-names>M</given-names></name><name><surname>Krueger-Burg</surname><given-names>D</given-names></name><name><surname>Tuffy</surname><given-names>LP</given-names></name><etal></etal></person-group>:
<article-title>Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.</article-title>
<source/><italic>Cell Rep.</italic>
<year>2015</year>;<volume>13</volume>(<issue>3</issue>):<fpage>516</fpage>–<lpage>23</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.011</pub-id>
<pub-id pub-id-type="pmid">26456829</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725845877">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-219">
<label>219</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parente</surname><given-names>DJ</given-names></name><name><surname>Garriga</surname><given-names>C</given-names></name><name><surname>Baskin</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.</article-title>
<source/><italic>Am J Med Genet A.</italic>
<year>2017</year>;<volume>173</volume>(<issue>1</issue>):<fpage>213</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.a.37977</pub-id>
<pub-id pub-id-type="pmid">27865048</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726993711">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-220">
<label>220</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>MC</given-names></name><name><surname>Qin</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Identification and functional characterization of rare mutations of the neuroligin-2 gene (
<italic>NLGN2</italic>) associated with schizophrenia.</article-title>
<source/><italic>Hum Mol Genet.</italic>
<year>2011</year>;<volume>20</volume>(<issue>15</issue>):<fpage>3042</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddr208</pub-id>
<!--<pub-id pub-id-type="pmcid">3131045</pub-id>-->
<pub-id pub-id-type="pmid">21551456</pub-id></mixed-citation>
</ref>
<ref id="ref-221">
<label>221</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>HG</given-names></name><name><surname>Kishikawa</surname><given-names>S</given-names></name><name><surname>Higgins</surname><given-names>AW</given-names></name><etal></etal></person-group>:
<article-title>Disruption of neurexin 1 associated with autism spectrum disorder.</article-title>
<source/><italic>Am J Hum Genet.</italic>
<year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>199</fpage>–<lpage>207</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.011</pub-id>
<!--<pub-id pub-id-type="pmcid">2253961</pub-id>-->
<pub-id pub-id-type="pmid">18179900</pub-id></mixed-citation>
</ref>
<ref id="ref-222">
<label>222</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Gumus</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Comparative genome hybridization suggests a role for
<italic>NRXN1</italic> and
<italic>APBA2</italic> in schizophrenia.</article-title>
<source/><italic>Hum Mol Genet.</italic>
<year>2008</year>;<volume>17</volume>(<issue>3</issue>):<fpage>458</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddm323</pub-id>
<pub-id pub-id-type="pmid">17989066</pub-id></mixed-citation>
</ref>
<ref id="ref-223">
<label>223</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Ingason</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Neurexin 1 (
<italic>NRXN1</italic>) deletions in schizophrenia.</article-title>
<source/><italic>Schizophr Bull.</italic>
<year>2009</year>;<volume>35</volume>(<issue>5</issue>):<fpage>851</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1093/schbul/sbp079</pub-id>
<!--<pub-id pub-id-type="pmcid">2728827</pub-id>-->
<pub-id pub-id-type="pmid">19675094</pub-id></mixed-citation>
</ref>
<ref id="ref-224">
<label>224</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etherton</surname><given-names>MR</given-names></name><name><surname>Blaiss</surname><given-names>CA</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name><etal></etal></person-group>:
<article-title>Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2009</year>;<volume>106</volume>(<issue>42</issue>):<fpage>17998</fpage>–<lpage>8003</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0910297106</pub-id>
<!--<pub-id pub-id-type="pmcid">2764944</pub-id>-->
<pub-id pub-id-type="pmid">19822762</pub-id></mixed-citation>
</ref>
<ref id="ref-225">
<label>225</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rabaneda</surname><given-names>LG</given-names></name><name><surname>Robles-Lanuza</surname><given-names>E</given-names></name><name><surname>Nieto-González</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>Neurexin dysfunction in adult neurons results in autistic-like behavior in mice.</article-title>
<source/><italic>Cell Rep.</italic>
<year>2014</year>;<volume>8</volume>(<issue>2</issue>):<fpage>338</fpage>–<lpage>46</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.06.022</pub-id>
<pub-id pub-id-type="pmid">25017069</pub-id></mixed-citation>
</ref>
<ref id="ref-226">
<label>226</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de la Peña</surname><given-names>JB</given-names></name><name><surname>Dela Peña</surname><given-names>IJ</given-names></name><name><surname>Custodio</surname><given-names>RJ</given-names></name><etal></etal></person-group>:
<article-title>Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).</article-title>
<source/><italic>Mol Neurobiol.</italic>
<year>2017</year>;<fpage>1</fpage>–<lpage>16</lpage>.
<pub-id pub-id-type="doi">10.1007/s12035-017-0608-1</pub-id>
<pub-id pub-id-type="pmid">26708209</pub-id></mixed-citation>
</ref>
<ref id="ref-227">
<label>227</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salatino-Oliveira</surname><given-names>A</given-names></name><name><surname>Genro</surname><given-names>JP</given-names></name><name><surname>Chazan</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Association study of
<italic>GIT1</italic> gene with attention-deficit hyperactivity disorder in Brazilian children and adolescents.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<year>2012</year>;<volume>11</volume>(<issue>7</issue>):<fpage>864</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2012.00835.x</pub-id>
<pub-id pub-id-type="pmid">22897819</pub-id></mixed-citation>
</ref>
<ref id="ref-228">
<label>228</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>van der Voet</surname><given-names>M</given-names></name><name><surname>Harich</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Converging evidence does not support
<italic>GIT1</italic> as an ADHD risk gene.</article-title>
<source/><italic>Am J Med Genet B Neuropsychiatr Genet.</italic>
<year>2015</year>;<volume>168</volume>(<issue>6</issue>):<fpage>492</fpage>–<lpage>507</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.b.32327</pub-id>
<pub-id pub-id-type="pmid">26061966</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725548136">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-229">
<label>229</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>KR</given-names></name><name><surname>Davenport</surname><given-names>EC</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>GIT1 and βPIX are essential for GABA
<sub>A</sub> receptor synaptic stability and inhibitory neurotransmission.</article-title>
<source/><italic>Cell Rep.</italic>
<year>2014</year>;<volume>9</volume>(<issue>1</issue>):<fpage>298</fpage>–<lpage>310</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.061</pub-id>
<!--<pub-id pub-id-type="pmcid">4536293</pub-id>-->
<pub-id pub-id-type="pmid">25284783</pub-id></mixed-citation>
</ref>
<ref id="ref-230">
<label>230</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arias-Vásquez</surname><given-names>A</given-names></name><name><surname>Altink</surname><given-names>ME</given-names></name><name><surname>Rommelse</surname><given-names>NN</given-names></name><etal></etal></person-group>:
<article-title>
<italic>CDH13</italic> is associated with working memory performance in attention deficit/hyperactivity disorder.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<year>2011</year>;<volume>10</volume>(<issue>8</issue>):<fpage>844</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00724.x</pub-id>
<pub-id pub-id-type="pmid">21815997</pub-id></mixed-citation>
</ref>
<ref id="ref-231">
<label>231</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Dempfle</surname><given-names>A</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder.</article-title>
<source/><italic>Am J Med Genet B Neuropsychiatr Genet.</italic>
<year>2008</year>;<volume>147B</volume>(<issue>8</issue>):<fpage>1392</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1002/ajmg.b.30878</pub-id>
<!--<pub-id pub-id-type="pmcid">2890047</pub-id>-->
<pub-id pub-id-type="pmid">18988193</pub-id></mixed-citation>
</ref>
<ref id="ref-232">
<label>232</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rivero</surname><given-names>O</given-names></name><name><surname>Sich</surname><given-names>S</given-names></name><name><surname>Popp</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Impact of the ADHD-susceptibility gene
<italic>CDH13</italic> on development and function of brain networks.</article-title>
<source/><italic>Eur Neuropsychopharmacol.</italic>
<year>2013</year>;<volume>23</volume>(<issue>6</issue>):<fpage>492</fpage>–<lpage>507</lpage>.
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.06.009</pub-id>
<pub-id pub-id-type="pmid">22795700</pub-id></mixed-citation>
</ref>
<ref id="ref-233">
<label>233</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Killen</surname><given-names>AC</given-names></name><name><surname>Barber</surname><given-names>M</given-names></name><name><surname>Paulin</surname><given-names>JJW</given-names></name><etal></etal></person-group>:
<article-title>Protective role of Cadherin 13 in interneuron development.</article-title>
<source/><italic>Brain Struct Funct.</italic>
<year>2017</year>;<volume>222</volume>(<issue>8</issue>):<fpage>3567</fpage>–<lpage>3585</lpage>.
<pub-id pub-id-type="doi">10.1007/s00429-017-1418-y</pub-id>
<!--<pub-id pub-id-type="pmcid">5676827</pub-id>-->
<pub-id pub-id-type="pmid">28386779</pub-id></mixed-citation>
</ref>
<ref id="ref-234">
<label>234</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benarroch</surname><given-names>EE</given-names></name></person-group>:
<article-title>GABA
<sub>B</sub> receptors: structure, functions, and clinical implications.</article-title>
<source/><italic>Neurology.</italic>
<year>2012</year>;<volume>78</volume>(<issue>8</issue>):<fpage>578</fpage>–<lpage>84</lpage>.
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318247cd03</pub-id>
<pub-id pub-id-type="pmid">22351795</pub-id></mixed-citation>
</ref>
<ref id="ref-235">
<label>235</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Jan</surname><given-names>LY</given-names></name><name><surname>Stoffel</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>G protein-coupled inwardly rectifying K
<sup>+</sup> channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons.</article-title>
<source/><italic>Neuron.</italic>
<year>1997</year>;<volume>19</volume>(<issue>3</issue>):<fpage>687</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80381-5</pub-id>
<pub-id pub-id-type="pmid">9331358</pub-id></mixed-citation>
</ref>
<ref id="ref-236">
<label>236</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>SR</given-names></name></person-group>:
<article-title>Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits.</article-title>
<source/><italic>Nature.</italic>
<year>1996</year>;<volume>380</volume>(<issue>6571</issue>):<fpage>255</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/380255a0</pub-id>
<pub-id pub-id-type="pmid">8637575</pub-id></mixed-citation>
</ref>
<ref id="ref-237">
<label>237</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mintz</surname><given-names>IM</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name></person-group>:
<article-title>GABA
<sub>B</sub> receptor inhibition of P-type Ca
<sup>2+</sup> channels in central neurons.</article-title>
<source/><italic>Neuron.</italic>
<year>1993</year>;<volume>10</volume>(<issue>5</issue>):<fpage>889</fpage>–<lpage>98</lpage>.
<pub-id pub-id-type="doi">10.1016/0896-6273(93)90204-5</pub-id>
<pub-id pub-id-type="pmid">8388225</pub-id></mixed-citation>
</ref>
<ref id="ref-238">
<label>238</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizukami</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Immunohistochemical localization of gamma-aminobutyric acid
<sub>B</sub> receptor in the hippocampus of subjects with schizophrenia.</article-title>
<source/><italic>Neurosci Lett.</italic>
<year>2000</year>;<volume>283</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1016/S0304-3940(00)00939-3</pub-id>
<pub-id pub-id-type="pmid">10739885</pub-id></mixed-citation>
</ref>
<ref id="ref-239">
<label>239</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizukami</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Hidaka</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Immunohistochemical localization of GABA
<sub>B</sub> receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain.</article-title>
<source/><italic>Prog Neuropsychopharmacol Biol Psychiatry.</italic>
<year>2002</year>;<volume>26</volume>(<issue>2</issue>):<fpage>393</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/S0278-5846(01)00247-0</pub-id>
<pub-id pub-id-type="pmid">11817519</pub-id></mixed-citation>
</ref>
<ref id="ref-240">
<label>240</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Mizukami</surname><given-names>K</given-names></name><name><surname>Iwakiri</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.</article-title>
<source/><italic>Neurosci Lett.</italic>
<year>2005</year>;<volume>383</volume>(<issue>3</issue>):<fpage>272</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neulet.2005.04.025</pub-id>
<pub-id pub-id-type="pmid">15955420</pub-id></mixed-citation>
</ref>
<ref id="ref-241">
<label>241</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Thuras</surname><given-names>PD</given-names></name></person-group>:
<article-title>Deficits in GABA
<sub>B</sub> receptor system in schizophrenia and mood disorders: a postmortem study.</article-title>
<source/><italic>Schizophr Res.</italic>
<year>2011</year>;<volume>128</volume>(<issue>1–3</issue>):<fpage>37</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1016/j.schres.2010.12.025</pub-id>
<!--<pub-id pub-id-type="pmcid">3085603</pub-id>-->
<pub-id pub-id-type="pmid">21303731</pub-id></mixed-citation>
</ref>
<ref id="ref-242">
<label>242</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selten</surname><given-names>MM</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Ba</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Increased GABA
<sub>B</sub> receptor signaling in a rat model for schizophrenia.</article-title>
<source/><italic>Sci Rep.</italic>
<year>2016</year>;<volume>6</volume>: 34240.
<pub-id pub-id-type="doi">10.1038/srep34240</pub-id>
<!--<pub-id pub-id-type="pmcid">5043235</pub-id>-->
<pub-id pub-id-type="pmid">27687783</pub-id></mixed-citation>
</ref>
<ref id="ref-243">
<label>243</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wierońska</surname><given-names>JM</given-names></name><name><surname>Kusek</surname><given-names>M</given-names></name><name><surname>Tokarski</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>The GABA
<sub>B</sub> receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.</article-title>
<source/><italic>Br J Pharmacol.</italic>
<year>2011</year>;<volume>163</volume>(<issue>5</issue>):<fpage>1034</fpage>–<lpage>47</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01301.x</pub-id>
<!--<pub-id pub-id-type="pmcid">3130949</pub-id>-->
<pub-id pub-id-type="pmid">21371011</pub-id></mixed-citation>
</ref>
<ref id="ref-244">
<label>244</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wierońska</surname><given-names>JM</given-names></name><name><surname>Kłeczek</surname><given-names>N</given-names></name><name><surname>Woźniak</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>mGlu
<sub>5</sub>-GABA
<sub>B</sub> interplay in animal models of positive, negative and cognitive symptoms of schizophrenia.</article-title>
<source/><italic>Neurochem Int.</italic>
<year>2015</year>;<volume>88</volume>:<fpage>97</fpage>–<lpage>109</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuint.2015.03.010</pub-id>
<pub-id pub-id-type="pmid">25863284</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725436876">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-245">
<label>245</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group>:
<article-title>The dialectic of Hebb and homeostasis.</article-title>
<source/><italic>Philos Trans R Soc Lond B Biol Sci.</italic>
<year>2017</year>;<volume>372</volume>(<issue>1715</issue>): pii: 20160258.
<pub-id pub-id-type="doi">10.1098/rstb.2016.0258</pub-id>
<!--<pub-id pub-id-type="pmcid">5247594</pub-id>-->
<pub-id pub-id-type="pmid">28093556</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>